Ultrahigh resolution optical coherence tomography for the detection of early stage neoplastic pathologies by Hsiung, Pei-Lin, 1975-
Ultrahigh Resolution Optical Coherence Tomography
for the Detection of Early Stage Neoplastic Pathologies
by
Pei-Lin Hsiung
M.S. in Electrical Engineering
Massachusetts Institute of Technology, 2000
B.S.E. in Electrical Engineering
Princeton University, 1997
Submitted to the
DEPARTMENT OF ELECTRICAL ENGINEERING AND COMPUTER SCIENCE
in partial fulfillment of the requirements for the degree of
DOCTOR OF PHILOSOPHY in ELECTRICAL ENGINEERING AND
COMPUTER SCIENCE
at the
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
April 2005
@2005 Massachusetts Institute of Technology. All rights reserved.
Signature of Author:
Department of Electrical
OF TECHNOLOGY
OCT 2 1 2005
LIBRARIES
Engineering and Compu r Science
'April 200SARKER
Certified by:
(J James G. FujimotoProfessor of Electrical Engineering
Thesis Supervisor
Accepted by:
Arthur C./Siith
Chair, Department Committee on Graduate Students
MwodlqF"4 m
Ultrahigh Resolution Optical Coherence Tomography
for the Detection of Early Stage Neoplastic Pathologies
by
Pei-Lin Hsiung
Submitted to the Department of Electrical Engineering and Computer Science
in April, 2005 in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy
ABSTRACT
Identification of changes associated with early stage disease remains a critical objective of
clinical detection and treatment. Effective screening and detection is important for improving
outcome because advanced disease, such as metastatic cancer, can be difficult to impossible to
cure. Many existing diagnostic modalities, including x-ray imaging, magnetic resonance
imaging, ultrasound, and endoscopy do not have sufficient resolution to detect changes in
architectural morphology associated with early neoplasia and other pathologies. Diagnostic
modalities capable of identifying pre-malignant tissue at an early stage could therefore
significantly improve treatment outcome.
Optical coherence tomography (OCT) is an emerging biomedical imaging technique that can
potentially be used as an in vivo tool for identifying early stage neoplastic pathologies. Recent
advances in solid-state laser and nonlinear fiber technology have enabled the development of
ultrahigh resolution and spectroscopic OCT techniques which promise to improve tissue
differentiation and image contrast. Previous ex vivo, benchtop ultrahigh resolution OCT imaging
studies suggest that differentiation of architectural morphology associated with pathology is
feasible. This thesis covers the development and investigation of ultrahigh resolution OCT for
studies of early neoplastic pathologies. A section of this thesis will focus on development and
evaluation of a novel turn-key broadband source for OCT. Feasibility studies were performed
using ultrahigh resolution OCT for imaging human tissues ex vivo in the clinical pathology
laboratory setting. Imaging results will be presented examining a variety of normal and
neoplastic lesions in preliminary studies of the thyroid gland, large and small intestine, and
breast. These experiments elucidate the optimal imaging parameters, potential and limitations of
the technique, and establish the microstructural markers visible in OCT images that are
characteristic of pathologic tissues. These studies establish a baseline which should help interpret
future in vivo ultrahigh resolution OCT imaging studies.
Thesis Supervisor: James G. Fujimoto
Title: Professor of Electrical Engineering
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Chapter 1
Introduction
Overview
According to the America Cancer Society, almost 574,000 Americans are expected to die of
cancer in 2004. Cancer is the second leading cause of death in the United States, exceeded only
by heart disease.' Despite these grim statistics, the age-adjusted mortality rate for the four most
common cancer types have remained constant or declined since 1990.2 Greater awareness of risk
factors, improvements in screening methods and increased compliance with screening guidelines,
and advances in treatment have undoubtedly improved patient outcome.
As with any disease, early detection and treatment can significantly improve patient prognosis.
Detection of cancer at an early stage before it becomes metastatic increases treatment options.
For these reasons, techniques for early cancer detection and treatment are active fields of
research. Optical coherence tomography (OCT), emerging optical imaging technique capable of
rapid noninvasive imaging of tissue cross-sectional microstructure, could provide a useful
adjunct to current diagnostic tools for detecting early stage cancer and managing treatment once
disease is diagnosed.' Early ex vivo studies in our group suggested the feasibility of using OCT
for the detection of early neoplasia in the reproductive, gastrointestinal, respiratory, and urinary
tracts. 5~9 Recent advances in OCT technology have improved imaging resolution and speed,
enabling ultrahigh resolution OCT imaging in the clinical setting to be performed.
In order to provide a background for the remainder of this thesis, this introductory chapter will
give a brief overview of cancer management, highlighting the role of various emerging imaging
techniques. The advantages and shortcomings of these imaging techniques will be discussed.
Optical coherence tomography will then be presented as a method to overcome some of these
shortcomings. Finally, foreseeable limitations of OCT will be discussed.
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Cancer Management
Cancer is a group of diseases characterized by genetic alterations that result in loss of the normal
control mechanisms that regulate cell growth, morphogenesis and differentiation, often termed
"neoplasia." Normal cell growth is accompanied by orderly development and specialization. In
contrast, all cancers are associated with genetic mutations which alter cell growth and division.
Roughly 5-10% of all cancers are associated with an inherited genetic component that
2predisposes the patient to a significantly increased risk of a particular cancer. The remainder are
associated with genetic mutations which may result from internal factors, such a hormonal
effects, or external factors, such as smoking, exposure to carcinogenic toxins, or sunlight.10
Viruses have also been implicated in the development of cancer."' 12 Not all neoplasms are
malignant, and those that are invade and become metastatic through complex multi-step
processes. After initial cell proliferation, secretion of several angiogenic factors and
neovascularization from the surrounding tissue must occur if the tumor mass is to grow beyond a
few millimeters in size.' Invasion of the host stroma occurs 1' 16 and tumor cells spread to
locations throughout the body via the lymphatic and vascular system resulting in secondary
tumor development in specific host sites.17 Once metastatic cancer is established, treatment
efficacy is often limited.
Cancer exacts a costly toll in human suffering, lost productivity, and cost associated with
medical care. However, many cases of cancer in the United States could be prevented by
reducing exposure to known risk factors. Of the estimated 563,700 cancer deaths expected to
2occur in the United States in 2004, approximately 32% will be caused by tobacco use. Roughly
one-third will be related to poor nutrition, physical inactivity, overweight/obesity, and other
lifestyle factors.' Poverty is the most critical factor affecting health and longevity, influencing
lifestyle factors such as tobacco use and obesity, awareness of and compliance with screening
guidelines, and access to appropriate medical care. 19 Significant disparities in cancer incidence,
mortality, and survival exist between various demographic and socioeconomic groups. In an
effort to reduce the disparity that exists in the socioeconomically disadvantaged, the American
Cancer Society is working to raise awareness of inequalities in health care through education and
advocacy at the local through federal levels, lobbying for increased funding for targeted research,
and developing outreach services tailored to be culturally appropriate and language-specific for
underserved communities. The ultimate goal of these efforts is to reduce cancer incidence and
mortality and increase cancer survival in disadvantaged groups to levels comparable to that of
the general population. 2
Surveillance and Early Detection
Early detection of cancer is important because it increases the likelihood of treatment being
effective. Surveillance tests must detect early stage disease at a point where appropriate
treatments exist. The likelihood of the particular disease progressing to a more advanced stage
must also be taken into consideration. The most appropriate candidates for surveillance are
therefore cancers which are associated with significant morbidity, high prevalence of detectable
early stage disease, possibility of improved outcome because of early detection due to
availability of improved early stage treatments methods, and existence of an effective, low-cost
screening test.20 Surveillance and screening programs have been shown to reduce mortality
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associated with cancers of the breast, cervix, colon and rectum. Surveillance programs have also
been linked to reduced mortality associated with other cancers, but studies are less conclusive.2
An unfortunate number of cancers are still discovered only after the onset of secondary
symptoms.
Staging
Cancer is further described as in situ if it is confined to the tissue of origin. The goal of early
detection would be to identify disease at an in situ stage or earlier, before the onset of either local
invasion or metastasis.
Once a diagnosis of cancer is established, the disease must be staged in order to estimate patient
prognosis and determine appropriate treatment. Staging is the process used to describe the extent
or spread of disease with malignant potential from the site of origin. Summary descriptive
staging systems are used to categorize invasive cancers as local (confined to organ of origin),
regional (extension into surrounding organs, tissues, or involvement of regional lymph nodes), or
distant (spread to regions remote from primary tumor). The commonly used TNM staging system
classifies tumors into categories based on extent of the primary tumor (T), involvement of lymph
nodes (N), and absence or presence of metastasis (M). Stage numbers I, II, III, and IV further
subdivide these categories into early (I) through late stage (IV). 2
Treatment
Treatment methods depend on the stage of the cancer and in many cases on the particular cancer
subtype. The benefit of treatment must be balanced with age, the overall health of the patient,
and treatment risk. This is especially important as over 76% of cancers occur in people age 55
and over.2 Radiation therapy is one of the most common treatments for cancer. Over half of all
cancer patients receive radiation at some point in their treatment process, whether as the sole
treatment or as adjuvant therapy post-surgery to eliminate possible residual disease. Radiation is
usually given locally through external means or through internally delivery via a radioactive
implant. Because it is given locally, side-effects are usually limited to the region of treatment.2 1
Chemotherapy, in contrast, is a systemic treatment which is useful for dealing with metastatic
disease. More recently, drugs can be targeted to local regions by local delivery methods such as
infusion pumps or controlled release implants. Chemotherapeutic drugs exist to cure disease,
control disease spread, and provide palliative care. Chemotherapy is also used as neoadjuvant
therapy to shrink the size of a tumor before subsequent radiation treatment or surgery.
Combinations of adjuvant therapies are also commonly used with surgery. Surgical procedures
themselves are the oldest form of cancer treatment. Advances in surgical techniques have
enabled procedures to be performed less invasively, often resulting in improved outcome and
shorter recovery time. Surgery also maintains an important role in staging of disease.
In addition to radiation, chemotherapy, and surgery, promising recent advances in harnessing the
body's natural immune system to fight cancer have led to the development of immunotherapy,
now considered a fourth treatment type for a number of cancers. Two categories of
immunotherapy include non-specific immunotherapies, which stimulate the immune system to
fight any cancer cells present, and monoclonal antibodies, which can be targeted to antigens
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produced by cancer cells or cancer-associated targets. Interleukin-2 was the first FDA-approved
immunotherapy for primary (non-adjuvant) use in treating advanced cancer.24 Interferons and
other cytokines, which are produced naturally by white blood cells in the body in response to
infection, have also been demonstrated to have an anti-tumor effect. Interferon-alfa, one of the
first interferons shown to slow tumor growth, is now FDA-approved for use for the treatment of
a number of cancers such as hairy cell leukemia, malignant melanoma, and follicular
lymphoma. Monoclonal antibodies have been widely used in scientific studies of cancer, as
26
well as in cancer diagnosis. As a therapy for cancer, monoclonal antibodies can be injected into
patients to identify cancer cells and potentially disrupt activity or enhance immune response
against the disease. Many clinical trials using monoclonal antibody treatments are underway, and
the FDA has approved several approaches for treating breast cancer, non-Hodgkin's lymphoma,
acute myelogenous and chronic lymphocytic leukemia, and colorectal cancer. 27 Much current
research is directed toward developing further methods to link cytotoxic drugs or radioisotopes
to monoclonal antibodies to enhance their specificity for tumor cells. The development of highly
specific delivery mechanisms could greatly enhance both early detection and treatment.
Imaging Techniques in Cancer Management
Of the many imaging techniques employed in cancer management, the only proven effective
imaging technique associated with cancer screening and improved patient outcome is low-dose
28
x-ray mammography for breast cancer. Increased use of mammography has been credited in
part for the majority of new breast cancer cases which are now detected at a localized stage,
where the five-year survival rate is currently 97%. 18 Newer methods such as spiral computed
tomography (spiral CT) are being investigated for efficacy and cost-effectiveness as a screening
tool for lung cancer. 29, 30 Magnetic resonance imaging (MRI) and positron-emission tomography
(PET) have also been investigated,31' 32 but because of their complexity, cost, and limited
sensitivity, have been used primarily for research investigations and for assessing distal
involvement. 33, 34 Transvaginal and transabdominal ultrasound have been investigated for
screening for ovarian cancers in high-risk populations because of the significantly increased
mortality associated with metastatic disease. 35, 36 With the exception of mammography, all of
these techniques are used after initial symptoms have arisen, and are unable to detect early stage
disease or assess abnormal lesions before they become invasive.
Once advanced disease is suspected, techniques such as CT and MRI provide high resolution
three-dimensional information useful for localizing lesions and staging disease for further
therapeutic procedures. Ultrasound has also been widely used and can be effective for a variety
of diagnostic applications. However, the effectiveness of ultrasound is operator-dependent and
limited to situations where direct probe contact is possible. Scarring and calcifications can
complicate ultrasound image interpretation. The presence of air also presents a formidable
barrier to ultrasound imaging, limiting applications in the respiratory tract. Transrectal
ultrasound and MRI has also been investigated for preoperative staging of prostate cancers,38 but
effectiveness has been limited due to inability to determine microscopic spread of disease. 34
More recently, endoscopic ultrasound (EUS) has proven itself to be a useful tool in the
assessment and staging of esophageal cancer39 and is being investigated for other organ
37, 4042systems. 2Endoscopic ultrasound enables higher resolution imaging than CT and MRI and
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can enable detection of some lesions less than 5 mm in diameter. However, EUS imaging is still
plagued by the fundamental resolution and contrast limitations of ultrasound.
A relatively new approach being investigated for gastrointestinal applications is real-time
magnification of endoscopic views to enable high-resolution imaging of mucosal surface
features, known as magnification endoscopy. Magnification endoscopes include adjustable
focusing mechanisms that allow magnification of the endoscopic image by 1.5x to 150x. 43
Magnification endoscopy is designed to be used with topical application of dyes such as
methylene blue to enhance visualization of mucosal structures. Improvements in endoscope CCD
technology have increased pixel densities from 100,000 to 200,000 pixels for conventional
endoscopes to 850,000 pixels some of the newest commercially available endoscopes.44'45 These
high-resolution magnification endoscopes are capable of visualizing structures as small as 10-71
microns in diameter, 45 and have been investigated for assessing flat colonic lesions and polyps,46'
'' Barrett's esophagus,48 and esophageal adenocarcinoma. While initial results are promising,
insufficient data exists to suggest routine use of magnification endoscopy in clinical procedures.
Limitations of Biopsy
Regardless of type of cancer, however, confirmation of the existence of disease is still based on
the "gold standard" of microscopic examination of representative tissue specimens obtained from
the suspicious lesion. Methods to obtain tissue samples include: fine-needle aspiration (FNA)
biopsy, used for the breast and hard-to-reach organs such as lung and liver; core needle biopsy,
which is more invasive than FNA but obtains more histologic material; cone biopsy, used to
diagnose and sometimes treat cervical cancer; endoscopic biopsy, performed in luminal organs
under visual endoscopic guidance; surface and punch biopsy, used for easier-to-access areas such
as skin and oral mucosa; and excisional and incisional biopsy. 50 The particular type of biopsy
method chosen depends on the tissue type being sampled, how suspicious the lesion appears
from previous diagnostic tests, the location and number of suspicious lesions, the general health
and preference of the patient, as well as the technical expertise available at the host hospital.
The choice of appropriate treatment ultimately depends on accurate and definitive diagnosis.
Although histologic assessment remains the gold standard by which a diagnosis of cancer is
determined, conventional biopsy followed by cytology or histolopathology still suffers from a
number of limitations which affect diagnostic outcome. Early disease, such as dysplasia and in
situ carcinoma, may not be visible using clinically available imaging methods. Ultrasound and
CT are often used to guide biopsy procedures for macroscopic lesions, but cannot identify early
disease or visualize the full extent of abnormal lesions because of the limited imaging resolution
and contrast. Screening biopsies, which are performed in patients with conditions which
predispose them toward developing certain cancers, are often performed using unguided
sampling protocols. An imaging technique capable of detecting early neoplastic changes and
microscopic invasion could therefore complement existing diagnostic modalities by guiding
biopsy, reducing sampling error and false negative rates, and guiding interventional procedures.
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Optical Coherence Tomography
Optical coherence tomography (OCT) is an emerging biomedical imaging technology which
permits rapid, noninvasive imaging of tissue microstructure in situ and in real time.3 4 OCT is
similar to ultrasound, except that near-infrared light is used instead of sound to probe tissue
internal structure. OCT detects backscattered light from different depths within a tissue sample,
thus generating a two-dimensional map of optical scattering as a function of depth. Optical
coherence tomography has several advantages over existing clinical imaging techniques which
make it attractive for a number of applications. OCT has resolutions higher than clinical
ultrasound and imaging can be performed without contact and without the use of a tranducing
medium. In addition, since OCT is an optical imaging technique, it can be incorporated into a
number of imaging devices such as laparoscopes, fiber-optic catheters, and imaging needles.5 s
Since the technique was initially reported in 1991, optical coherence tomography has been
extensively investigated in ophthalmology, in part because of the unique accessibility of the
anterior and posterior eye to optical imaging techniques. The lack of a competing clinical
technology for cross-sectional imaging of retinal microstructure has led to relatively rapid
development and adoption of OCT technology for ophthalmology as an adjunct to standard
clinical care. Progress has also been made in the development of OCT for high-resolution
catheter-based imaging of architectural morphology associated with cardiovascular disease.
60
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Feasibility studies have also been performed in preliminary studies of the respiratory, female
reproductive, and urinary tracts. With the development of fiber optic catheters, in vivo
endoscopic OCT imaging in an animal model was demonstrated.5 ' Today, with the exception of
ophthalmology and cardiology, the majority of in vivo OCT investigations have been pursued in
the gastrointestinal tract6473 Much of this clinical work has focused on the upper gastrointestinal
tract, where excellent sensitivities and specificities have been demonstrated for detecting
Barrett's esophagus, a condition which predisposes patients to increased risk of developing
72
esophageal adenocarcinoma. Recent work has shown that OCT has potential to distinguish
hyperplastic from adenomatous polyps in the colon.73
OCT for early detection
Over 55% of new cancer cases in the United States in 2004 will occur in the lung and bronchus,
breast, prostate, colon and rectum.2 Of these new cases, approximately 95-98% will be cancers of
epithelial origin, known as "carcinomas." Early detection techniques would be particularly
powerful if epithelial abnormalities known as dysplasia could be identified. Advanced stages of
dysplasia are correlated with high likelihood of progressing into cancer.74' 7 Dysplastic tissue
exhibits specific alterations in epithelial cells which are typically characterized histologically.
These can include dark-staining nuclei (hyperchromatism), enlarged and prominent nuclei,
increased mitotic figures (indicating abnormal cell division), and increased nuclear-to-
cytoplasmic (N/C) ratio. Epithelial cells may also appear crowded and bunched together. In
stratified squamous epithelium, abnormal cell maturation from the basal layer to the superficial
layer is also a hallmark of dysplasia. These microstructural changes affect the optical scattering
properties of the epithelium and may be detectable using OCT. Dysplastic changes may also be
associated with architectural changes, such as alterations in the size, shape, and distribution of
glandular structures. Specific mucosal pit patterns viewed using magnification endoscopy have
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been correlated with neoplastic colonic lesions well as Barrett's esophagus.76' 77 While
identification of features associated with cellular-level changes may prove to be difficult, OCT
may still enable identification of neoplastic lesions based on architectural microstructure.
The large numbers of patients involved in studies performed in the upper gastrointestinal tract
indicates significant interest in the potential of OCT for detecting early stage esophageal cancers.
Carcinomas of the gastrointestinal tract are particularly amenable to catheter-based imaging
techniques. Current endoscopic methods for biopsy guidance provide only surface information
and are prone to sampling errors. If microstructural changes associated with early stage
neoplasias prove to be visible, OCT could be used to guide excisional biopsy, potentially
increasing diagnostic yield and reducing false negative rates. OCT could also potentially be used
to identify tumor margins and guide minimally invasive surgery.
Limitations of OCT
While OCT is promising for detecting a number of architectural changes associated with early
neoplastic lesions, a number of limitations exist which may eventually limit the role of OCT in
cancer management. OCT performs imaging using light in the near-infrared range, avoiding the
primary absorption bands of water and the primary tissue chromophores. Even in this wavelength
range, OCT image penetration depth is limited to a few millimeters because of depth-dependent
attenuation due to scattering. Variations in penetration depth are apparent in individual images
which are composed of different tissue constituents, complicating image interpretation. Adipose
tissue and certain protein colloids, for example, exhibit less attenuation than fibrous connective
tissue. While the penetration depth can be increased to some degree by increasing optical power
used for imaging, incident power is ultimately limited by American National Standards Institute
(ANSI) values established to prevent tissue damage. Imaging sensitivity can also be increased at
the expense of imaging speed. However, the penetration depth in OCT images should be
sufficient to assess mucosal microstructural features associated with most hollow organs. OCT
imaging may therefore complement standard ultrasound by providing high resolution assessment
of mucosal features which cannot be visualized using current imaging methods. In addition, OCT
imaging needles may eventually enable imaging of solid organs. In this scenario, image
penetration depth would primarily be limited by the depth of insertion of a needle-based device.
The most significant limitation of OCT may be inherent lack of contrast between structures
which must be visualized in order to differentiate normal tissue from neoplastic pathology.
Although it is recognized that the source of contrast in OCT is related to tissue microstructure
and index of refraction, the nature of this relationship is still poorly understood. Light scattering
in tissue is affected by the shape, size, and distribution of tissue constituents and their relative
indices of refraction. Various theoretical models have been proposed which suggest that the
primary sources of scattering in tissue are cellular components on the order of the wavelength of
the incident light or smaller. 78' 79 For imaging in the 600-1400 nm near-infrared range, this
suggests that nuclei, other cytoplasmic organelles, and membranes strongly contribute to tissue
scattering. In addition, scattering would also be expected from supporting tissue constituents
such as collagen, which range from -100 nm diameter individual fibrils to several micron
diameter bundles.8 0 The utility of OCT for differentiating normal tissue from pathology will
therefore likely depend on alterations in normal scattering properties of these constituents which
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can be detected using OCT. This suggests that new diagnostic criteria for early cancers different
from those used in standard histopathology may need to be developed in order to realize the full
potential of OCT as a diagnostic tool. Research and development focused on novel contrast
mechanisms may eventually overcome the inherent visualization limitations of standard
scattering intensity-based OCT imaging. 81-84
Scope of Thesis
The main goal of this thesis is to investigate the hypothesis that OCT can be used as an in vivo
tool for the identification of early neoplastic pathologies. Previous ex vivo, benchtop ultrahigh
resolution OCT imaging studies have suggested that differentiation of architectural morphology
associated with neoplastic pathology is feasible. However, imaging in the laboratory setting
limited access to tissue and imaging could often only be performed on fixed specimens or
postmortem tissue. Recent advances in solid-state laser and nonlinear fiber technology have
enabled the development of ultrahigh resolution and spectroscopic OCT techniques which can
now be used in the clinical setting.
This thesis covers the development of a new source for ultrahigh resolution OCT imaging and
investigation of the performance of ultrahigh resolution OCT for studies of several human early
neoplastic pathologies in the clinical setting. In Chapter 2, the development and evaluation of a
novel broadband source for OCT will be presented. This source is compact, turn-key, and should
enable a wide range of new ultrahigh resolution, high-speed, OCT imaging applications. Early
features of cancer are often focal, with diagnosis which may often differ from slide to slide.
Precise registration with histology is therefore required for correlation of OCT imaging with
pathology and accurate interpretation. Chapter 3 first presents ultrahigh resolution OCT imaging
in vivo and ex vivo in an animal model to investigate the effects of tissue preservation and
fixation on optical contrast. This study establishes proper specimen handling protocol for ex vivo
imaging as well as provides a reference for interpreting histologic correlation with OCT in a
model system with representative tissue constituents. Chapters 4-6 will then present results
examining normal and neoplastic lesions in the thyroid gland, large and small intestine, and
breast. These studies establish a baseline which should help interpret future in vivo ultrahigh
resolution OCT imaging studies. Finally, Chapter 7 discusses possible future work investigating
OCT for identifying markers of dysplasia and presents preliminary in vivo ultrahigh resolution
OCT imaging results in the human gastrointestinal tract.
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Chapter 2
High-power, Continuous-wave, Raman Continuum Light
Source for Optical Coherence Tomography
INTRODUCTION
Optical coherence tomography (OCT) is an emerging biomedical imaging technology that can
perform high-speed, micron scale, noninvasive imaging of tissue morphology in vivo. The
principles of OCT have been described previously.3, 4 Since OCT is based on low-coherence
interferometry, the axial image resolution, Az, is determined by the bandwidth AX and the center
wavelength X0 of the light source: Az = [21n(2)/t](Xo 2/AX). Standard OCT systems use
superluminescent diode light sources, which achieve an axial resolution of 10-15 pm. Compact
and portable high performance broadband light sources with sufficient power and bandwidth are
important to achieve ultrahigh resolution, high-speed OCT imaging outside the laboratory
setting.
Femtosecond solid-state lasers have been demonstrated to directly generate broad bandwidths
which can be used for ultrahigh resolution OCT imaging, but are difficult to operate outside the
laboratory. 85' 86 Nonlinear and microstructure fibers pumped by femtosecond bulk and fiber
systems have also enabled imaging with unprecedented resolutions, but require the use of
femtosecond lasers.87-89 Reductions in cost can be achieved using low-threshold femtosecond
lasers which use inexpensive low-power pump lasers, but these systems are still relatively
complex.90'91 Femtosecond fiber laser-based sources promise to be compact and robust.92 The
1300 nm wavelength region is of particular interest for biomedical applications because it
permits improved imaging depth when compared with shorter wavelengths due to reduced
scattering in biological tissue.9 ' The development of broadband light sources for OCT imaging
in scattering tissue has therefore focused on this wavelength range.87, 89, 92, 94 Recent work has
also investigated light source development and imaging in the 1000-1100 nm wavelength range,
which provides a compromise of higher resolution for a given bandwidth at the expense of
reduced image penetration. 95' 96 A portable source suitable for in vivo clinical applications has
been demonstrated in this wavelength range using a femtosecond diode-pumped Nd:Glass laser
with a highly nonlinear fiber.96
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This chapter describes a novel approach for broadband continuum generation in microstructure
fibers using a high-power, continuous-wave, all-fiber pump light source. This new light source
promises to enable ultrahigh resolution, high-speed OCT imaging with lower cost and
complexity than with femtosecond laser-based light sources. Microstructure fibers typically
have been pumped with femtosecond lasers to provide the peak powers necessary to initiate
nonlinear effects for continuum generation under conditions of anomalous or near-zero
dispersion. However, the use of high intensity femtosecond pulses for broadband continuum
generation under these conditions leads to severe spectral modulation of the continuum in the
vicinity of the pump wavelength. This spectral modulation produces sidelobes and reduced
contrast in the interferometric axial point spread function which degrades OCT image contrast.
Femtosecond pumping of microstructure fibers may also result in excessive temporal instability
of the continuum and nonlinearly amplified quantum noise, which can lead to excess intensity
noise.97
An alternative to using high peak powers is to increase the effective nonlinear interaction length
of the Raman interaction, which is governed by optical losses in the fiber and dispersive walk-off
between the pump and continuum pulses. The use of longer pump pulses reduces this dispersive
walk-off effect. Stimulated Raman scattering has been shown to be the principle nonlinearity for
continuum generation by using nanosecond-scale pump pulses.9 8' 99 Recently, the possibility of
low peak power and even continuous-wave, multiwatt Raman continuum generation in highly
nonlinear fibers has been demonstrated.100 Continuous-wave pumping of nonlinear fibers can
enable the development of robust and turnkey continuum light sources which require no optical
alignment, enabling high-speed, ultrahigh resolution OCT imaging in a wide range of
applications outside the laboratory.
This chapter demonstrates a new light source for ultrahigh resolution, high-speed OCT imaging
using Raman continuum generation from a continuous-wave pumped microstructure fiber. This
source achieves bandwidths of ~140 nm in the 1300 nm wavelength range with output powers of
330 mW, higher than achieved using any other technique. The light source is compact (25 x 25 x
20 cm), robust, completely turnkey, and requires no optical alignment. Ultrahigh resolution,
high-speed OCT imaging is demonstrated with < 5 pm axial resolutions. High-speed ultrahigh
resolution imaging is demonstrated in vivo in the hamster cheek pouch and in human skin.
SYSTEM PARAMETERS
The broadband all-fiber Raman continuum light source was based on a 10 W continuous-wave,
non-polarized, multimode diode-pumped, single-mode Yb-fiber laser (IPG Photonics) directly
spliced to an anomalously dispersive microstructure fiber (Crystal Fiber). The microstructure
fiber was 100 meters long, had a dispersion of +35 ps nm' km, a pitch of A = 1.72 pm, and an
air-hole diameter of 0.65 pm. Figure 2.1 shows a schematic of the source and the Raman
continuum output. The Raman-soliton continuum had 5.5 W of total power and a spectral width
of 318 nm (at 20 dB). The spectral range from 1090 to 1370 nm was flat to ±5 dB and contained
2.3 W of power. This output was filtered using a special WDM coupler to remove the pump
wavelength and to achieve a smooth, Gaussian-like spectrum in the 1300 nm wavelength range.
Figure 2.2A shows a typical spectrum before and after spectral shaping by the WDM coupler.
The output power after the coupler was ~330 mW and the spectrum was Gaussian-shaped with a
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bandwidth of -140 nm, corresponding to a theoretical resolution of 5 pm in free space. The all-
fiber light source contains no bulk optical components, requires no alignment, and is turnkey,
compact and robust.
The intensity noise of the light source system was characterized using an RF spectrum analyzer.
Figure 2.2B shows the noise spectrum of the Raman continuum generated by the source, the
detection system noise, and the calculated shot noise level. Excess intensity noise is caused in
part by feedback from the fiber-grating-based design of the Yb pump laser and reflection from
the splices between the microstructure fiber and the pump laser and WDM coupler. Dual-
balanced detection was used in the OCT system to reduce excess intensity noise.
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Figure 2.1: Left, Schematic of Raman continuum source. SMF: Single-mode fiber. Right,
Output spectrum. The output was 5.5W total, with 2.3 W in the spectral range from 1090 to 1370
nm. The output was filtered using a special WDM coupler to remove the pump wavelength and
shape the spectrum.
OCT System Input Spectrum
A
140 nm
330 mW
14130 1100 1200 1300
Wavelength (nm)
RF Noise Spectrum
a-8
.90 B
-1001 Source noise.
V-110
-120-
0-130-
0. -140 A
0-150 Syste noise0 Shot noise level
c
00 10
5 677
10 10 10 10
Frequency (Hz)
Figure 2.2: A. Typical output spectrum of the Raman fiber light source before and after spectral
shaping. B. RF noise spectrum. High frequency oscillations are caused by spurious reflections
from the fiber splices. Dual-balanced detection is used to reduce excess noise.
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Figure 2.3 shows the schematic of the experimental setup for OCT imaging. The system consists
of a dual-balanced interferometer with broadband 80/20 and 50/50 fiber couplers to optimize
power coupled back to the detectors. The reference arm was scanned using a reflective delay
scanner at a velocity of 6.2 m/s and 1600 Hz repetition rate. Polarization controllers were used
in both the sample arm and the reference arm. Dual-balanced detection with two InGaAs
photodiodes (Dl and D2) was used to reduce excess intensity noise in the light source. Since the
interference signal occurs 180 degrees out of phase at the two detectors, subtracting the two
signals adds the heterodyne interference signal but subtracts excess noise. The input to
photodiode D2 is attenuated to match the input to photodiode D1. It was important to match the
path lengths of the two arms of the double-detector receiver in order to achieve optimum noise
reduction. 101 The interference signal was electronically bandpass filtered, logarithmically
demodulated, low-pass filtered, and digitized. Detection was performed at a Doppler frequency
of 9.8 MHz with a bandwidth of 1.2 MHz.
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Figure 2.3: Schematic of high-speed, ultrahigh resolution OCT system using an all-fiber Raman
continuum light source. The system uses broadband 80/20 and 50/50 couplers to optimize the
power on the sample and coupled back to the detectors. Dispersion was matched in the sample and
reference arms of the interferometer in order to maintain high axial resolution.
In vivo imaging was performed using an XY galvanometer scanning probe. Near-infrared
achromatic lenses were used to minimize chromatic aberration. The fiber collimating lens had a
focal length of f, = 10 mm, followed by a Hopkins relay pair of lenses with focal lengths fi = 25
mm and f2 = 40 mm, and an objective of focal length fo = 25 mm. A pair of galvanometer-
controlled scanning mirrors was used between the fiber collimating lens and the Hopkins relay to
perform high-speed transverse scanning. The focused spot size was 2coo = 18 pim, corresponding
to a full-width-half-maximum of -11 pm. To minimize the effect of wavefront aberration,
dehydration, and to achieve better index matching, the tissues were irrigated with saline and
covered with a thin cover glass.
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RESULTS
The performance of the OCT system using the fiber Raman continuum light source was
characterized using an isolated reflection from a single mirror. To maintain axial resolution, the
dispersion in the interferometer sample and reference arms was carefully matched. Appropriate
thickness glass blanks of fused silica, SFL6, and LakN22 were inserted into the reference arm to
balance the dispersion of the achromatic lenses in the imaging probe. Dispersion mismatch was
monitored by taking the Fourier transform of the interferometer fringe signal. Figure 2.4A and
Figure 2.4B show the interference signal after bandpass filtering and the logarithmic
demodulated signal after lowpass filtering. The measured axial resolution was 6.3 Pm in air,
corresponding to 4.8 pm in tissue. The detected optical spectrum was measured to be 110 nm by
Fourier transformation of the interferometric signal. This reduction in bandwidth may be the
result of wavelength dependence of the fiber couplers as well as wavelength variations in the
sensitivity of the InGaAs photodiodes.
The system sensitivity was measured using the minimum visible intensity of a reflection from a
mirror and was 95 dB with an incident power of 20 mW. The theoretical sensitivity for this
incident power and detection bandwidth is 103 dB. Parasitic losses in the sample arm optics,
fiber couplers, and fiber connectors account for ~4 dB of the reduction in sensitivity. Incomplete
noise cancellation from mismatches in the fiber couplers and detectors may account for the
additional 4 dB reduction in sensitivity.
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Figure 2.4: A. Point spread function measured using an isolated 3.0 OD attenuated reflection from
a mirror. The axial resolution is 6.3 pm in air, corresponding to <5 pm in tissue. B.
Logarithmically demodulated signal showing low sidelobes.
Ultrahigh resolution, high-speed, in vivo OCT imaging using this source was demonstrated in
human skin as well as in the hamster cheek pouch, a well-established model for studies of cancer
progression. Imaging was performed using an XY scanning probe. Figure 2.5 shows high-
speed, ultrahigh resolution in vivo images of human skin. The image had 500 transverse pixels
and 1000 axial pixels and covered an area of 2.25 mm by 1.8 mm. Imaging was performed at a
rate of 3.2 frames per second. The axial dimension was scaled by 1.38 to account for the
approximate index of refraction of skin.'02 Distinct morphological features such as the
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keratinized stratum corneum, the junction between the dermis and epithelium, and sweat ducts
are clearly visualized in the ultrahigh resolution images.
Figure 2.5: In vivo high-speed OCT images of human skin. The stratum corneum layer (SC), epithelium
(E), dermis, dermal-epidermal junction (arrows, inset left) and a spiraling sweat duct (arrow, inset right)
can clearly be seen. Images were acquired at 3.2 frames per second. (~18 pm x 4.8 pm transverse x axial
resolution; 500 x 1000 pixels; 2.25 mm x 1.8 mm).
Figure 2.6: High-speed, ultrahigh resolution in vivo OCT image of Syrian hamster cheek pouch.
The keratinized epithelial layer (e), muscular layers (m), and two prominent vessels (v) are clearly
visible. A microscope cover glass (c) was placed over the top of the cheek pouch. (~18 pm x 4.8
pm transverse x axial resolution; 500 x 1000 pixels; 2.4 mm x 1.4 mm).
Figure 2.6 shows an in vivo image of hamster cheek pouch. Imaging was performed with the
animal under anesthesia and in accordance with approved protocol reviewed by the
Massachusetts Institute of Technology Committee on Animal Care (CAC). The ultrahigh
resolution images had 500 transverse pixels and 1000 axial pixels and covered an area of 2.4 mm
by 1.4 mm. The ultrahigh resolution OCT image exhibits structure associated with the normal
hamster cheek pouch. A thin, keratinized layer which is highly backscattering is present near the
surface, followed by an epithelial layer (e), muscular (m) layers, and connective tissue. Two
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prominent blood vessels (v) are also clearly visible within the muscular layers and connective
tissue. Image depths are comparable to those achieved with other 1.3 Pm light sources.
To demonstrate the high-speed imaging capability of this ultrahigh resolution OCT system, in
vivo three-dimensional imaging of human skin and hamster cheek pouch was also performed.
High-speed imaging enables volume datasets to be acquired, permitting tracking of
morphological features through the imaging volume. Each three-dimensional data set consisted
of sequentially acquired transverse OCT images, each containing 500 transverse pixels and 1000
axial pixels. Volume imaging of human skin consisted of 50 transverse images with 15 pm
spacing between frames, spanning an imaging volume of 2.25 mm x 0.750 mm x 1.8 mm.
Imaging of hamster cheek pouch consisted of 50 transverse images with 20 Pm spacing between
frames, spanning an imaging volume of 2.4 mm x 1.0 mm x 1.8 mm. The data was acquired at
3.2 frames per second, for a total acquisition time of -15 seconds for 500 x 50 x 1000 =
2,500,000 data points or voxels. The three-dimensional dataset can be displayed in various
orthogonal planes or rendered using image processing and rendering software.
Figure 2.7 shows an example of three-dimensional imaging of the hamster cheek pouch. In
Figure 2.7A, the three-dimensional data can be viewed in sequential transverse slices,
corresponding to the normal OCT view. This enables features such as the epithelial layer,
muscular layers, connective tissue, as well as two large blood vessels to be tracked through
successive image planes. In Figure 2.7B, the three-dimensional data is viewed using en face
slices at different depths, perpendicular to the normal OCT view, corresponding to the view
typically provided by confocal microscopy. The en face slices enable surface features such as
folds in the epithelium to be better visualized than in the transverse slices. Figure 2.8 shows a
rendered volume of the hamster cheek pouch constructed from the three-dimensional data set.
The rendered tissue volume can be viewed from arbitrary virtual perspectives. Videos showing
animations of sequential slices through the imaging volume are available in the supplementary
materials.
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Figure 2.7: Three-dimensional volume imaging using in vivo ultrahigh resolution OCT images
acquired at 3.2 frames per second. A. Sequential transverse slices of hamster cheek pouch with
two large vessels, corresponding to the normal OCT view. B. En face slices at different depths,
perpendicular to the OCT view, allowing features such as epithelial folds and vessels to be
visualized. Movies showing animations of sequential slices are available in the supplemental
materials. The rendered volumes cover 2.4 mm x 1.0 mm x 1.8 mm.
Figure 2.8: Rendered volume of hamster cheek pouch constructed from a three-dimensional
dataset. The tissue volume can be viewed from arbitrary virtual perspectives. The rendered volume
covers 2.4 mm x 1.0 mm by approximately 1.8 mm. A movie showing the rendered volume from
arbitrary perspectives is available in the supplemental materials.
Figure 2.9 shows examples of three-dimensional imaging in human skin. In Figure 2.9A, the
volume data can be displayed in enface slices at different depths through the human fingerpad.
Structures such as ridges in the stratum corneum associated with the fingerprint could be clearly
26
A B
seen. Sweat ducts could also be clearly seen spiraling along the ridges of the fingerpad through
the stratum corneum and into the epithelium. Three-dimensional rendering and segmentation
can be performed as shown in Figure 2.9B, enabling the density of sweat ducts as well as
individual ducts to be assessed (inset). Other structures such as the rete ridges in the junction
between the epithelium and dermis can also be visualized. Videos showing animations of
sequential slices through the fingerpad and the rendered ducts are available in the supplementary
materials.
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Figure 2.9: A. En face slices of human fingerpad created from cross-sectional images. Spiraling
sweat ducts could be seen along the fingerpad ridges (2.25 x 0.75 x 1.8 mm) B. 3D rendering and
segmentation of sweat ducts. Duct density as well as individual ducts can be assessed. Movies
showing virtual enface slices and animations are available in the supplemental materials.
CONCLUSION
In conclusion, this chapter demonstrated a new, high performance light source for high-speed,
ultrahigh resolution OCT imaging. Bandwidths of 140 nm in the 1300 nm wavelength range are
achieved, yielding axial resolutions of < 5 pm in tissue. The axial resolution of < 5 pm is
comparable to that achieved using much more complex femtosecond solid state sources such as
the Cr:Forsterite laser. Output powers of 330 mW enable high-speed, OCT imaging in vivo.
Output powers are comparable to or better than those available from femtosecond lasers, and
more than one order of magnitude higher than superluminescent diode sources. Since this light
source is all-fiber, it requires no alignment and provides completely turnkey operation. The
source is extremely compact, measuring only 25 x 25 x 20 cm, and can easily be integrated into
portable OCT systems. Excess noise is relatively high, but can be reduced using dual-balanced
detection. Further reduction in noise should be possible by reducing parasitic feedback effects in
the fiber splices and by techniques such as active seeding of the Raman process. Broader output
bandwidths should be achievable using higher pump power Yb-fiber lasers and different fiber
geometries. The bandwidth will ultimately be limited by the water absorption of microstructure
fibers which reduces the effective interaction length of the Raman scattering. The current cost of
the source is still relatively high due to the cost of the microstructure fiber. However, since
demand for microstructure fiber is increasing, the price of these fibers is decreasing and can be
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expected to approach that of other specialty fibers. The cost of continuous-wave Yb-fiber lasers
has also dramatically decreased in recent years. The cost of fiber Raman continuum light
sources will therefore be significantly lower than that of bulk solid-state femtosecond laser-based
light sources. The high performance and ease of use of the fiber Raman continuum source
promises to enable a wide range of new ultrahigh resolution, high-speed, OCT imaging
applications.
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Chapter 3
Effect of Tissue Preservation on Imaging using Ultrahigh
Resolution Optical Coherence Tomography
INTRODUCTION
Optical coherence tomography (OCT) is an emerging imaging modality which can generate
micron-resolution, cross-sectional images of tissue microstructure in situ and in real time.3' 4
Since the first demonstration in 1991, OCT has been investigated for imaging a number of
neoplastic pathologies.
Early OCT studies initially focused on ex vivo imaging to establish correlations with
histopathology and feasibility for future in vivo studies. 6-9, 103-109 With the development of fiber
optic endoscopes, in vivo OCT imaging in animals was demonstrated, 5 and not long afterwards
the first in vivo endoscopic imaging in humans was performed. 110 However, accurate registration
of OCT images with histology is difficult to achieve with in vivo imaging. Subsequent studies
investigating the effect of OCT imaging parameters on tissue structure identification in the
gastrointestinal tract have been performed ex vivo partly for this reason. 1 Previous studies in
ophthalmology have also investigated the effect of nonlinear shrinkage and sectioning stress
during histology preparation on subsequent interpretation of retinal microstructures.1 2
It is generally believed that non-negligible changes in tissue scattering characteristics are visible
within a few hours, motivating investigations to be performed as soon as possible after tissue
excision. However, the effect of tissue ischemia on optical scattering is still not well understood.
Prior studies in animal models have shown negligible changes in tissue reflectance up to 25
minutes after excision during immersion in 0.9% isotonic saline," 3 and fluorescence and diffuse
reflectance studies showed preservation of 70-90% of spectroscopic signal intensity up to 1.5
hours after biopsy." 4 In addition, the timecourse of these changes post-excision has not been
investigated. Previous studies involving ex vivo imaging of tissue specimens have reported
imaging times after tissue harvest ranging from 30 minutes'0 9' 115, 116 to 5 hours.105-10 8 Imaging
has also been performed on formalin-fixed specimens,"' previously frozen specimens, 17' 117 and
on specimens harvested from cadavers.6' 105, 106, 108, 118 Isotonic saline has typically been used for
specimen irrigation and transport,8 ' 9, 67, 107, 109, 115 but buffered saline6' 105, 106, 108 and Hank's
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solution have also been used.109 Studies comparing protocols for tissue preservation for ex vivo
imaging have not been reported in the literature.
The objectives of this study were to investigate the effect of formalin fixation on imaging using
ultrahigh resolution OCT, and to test the effect of two commonly used laboratory culture media
on ex vivo preservation of tissue optical scattering characteristics over time. Standard formalin
fixation followed by paraffin-embedding leads to shrinkage and processing artifacts which
complicate image interpretation. Imaging at sequential timepoints during the fixation process
allows one-to-one correlation of tissue structures with histology, enabling accurate interpretation
of in vivo tissue architectural features. As it is not always possible in human studies to image
tissue specimens immediately after excision, the effect of post-excision imaging time on optical
scattering characteristics was also investigated. Imaging was performed on the same tissue
specimens in vivo and up to a maximum time of 10-18 hours after excision, enabling direct
comparison of in vivo versus ex vivo imaging.
This chapter investigates the effect of formalin fixation on imaging contrast using ultrahigh
resolution OCT, and describes the effect of two commonly used laboratory media on ex vivo
preservation of tissue optical contrast. The hamster cheek pouch was chosen for this study
because it consists of representative tissue components and is a commonly used system for the
study of tumorigenesis. When dosed with carcinogen, histological features in this model have
been shown to correspond closely with premalignant and malignant lesions in human oral
mucosa. 11 The tissue constituents in the hamster cheek pouch are representative of the
composition of human epithelial tissues such as oral mucosa, esophagus, and cervix. There has
been recent interest in investigating tumor development in this model using non-invasive optical
techniques. Fluorescence spectroscopy has been shown to detect biochemical changes associated
with early tumor development in this model.O' 1 Multiphoton microscopy and optical
coherence tomography have also recently demonstrated ability to detect early morphological
changes associated with cancer development in the hamster cheek pouch. 2 2', 123
In this study, three solutions were tested to assess their affect on tissue optical scattering
characteristics. First, 10% neutral-buffered formalin was investigated to determine the effect of
the fixation process on imaging using OCT. Formalin, consisting of 4% formaldehyde, is the
most common fixative used for routine paraffin-embedded sections. Formaldehyde acts by
forming cross-linkages between tissue proteins, fixing cellular constituents in their in vivo
positions and thus preventing autolytic processes.12 4 Although formalin penetrates tissue well,
the rate of tissue penetration is relatively slow.12 5 The second solution tested was isotonic
phosphate-buffered saline (PBS). PBS is a common solution used in many laboratory procedures,
often serving as medium for irrigating, transporting and diluting fluid. Isotonic PBS maintains
intra- and extra-cellular osmotic balance and a buffering system keeps the medium within the
physiological pH range. The third solution tested was Dulbecco's Modified Eagle's Media
(DMEM), a commonly used synthetic cell culture media. DMEM includes higher concentrations
of amino acids and vitamins than basal salt solutions as well as additional supplementary
components so that the medium more closely approximates the protein composition of
mammalian cells. The autolysis process begins immediately after tissue harvest. Tissue culture
media was expected to slow autolytic processes, slowing changes which may influence tissue
contrast. Sera, which contain additional supplements and growth factors and are typically added
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to media used for cell culture, were not added to DMEM in this study because the goal was to
investigate the performance of individual solutions on preservation of in vivo optical scattering
characteristics in order to minimize complexity associated with tissue handling protocols.
METHODS
Ultrahigh Resolution OCT System and Imaging Parameters
Ultrahigh resolution OCT imaging was performed using a state-of-the-art broadband Ti:A120 386laser operating at a center wavelength of 800 nm. Imaging was performed with an axial
resolution of 2 pm in free space, corresponding to ~1.5 pm in tissue. To achieve high transverse
resolution, an imaging probe consisting of two specially-designed achromatic doublets with 10
mm focal length was used, yielding a transverse resolution of -5 pm in air. The system
sensitivity was measured to be 103 dB with 3 mW of optical power on the sample. The imaging
probe was mounted on two precision computer-controlled micrometer stages to control imaging
in two lateral dimensions. All images acquired were 1 mm x 1 mm in dimension and consisted of
1000 axial x 1000 transverse pixels. This enabled an imaging sample density of 1 pixel/pm in
both axial and transverse dimensions.
Specimen selection and handling
All animal procedures were approved by the Committee on Animal Care (CAC) at the
Massachusetts Institute of Technology. The Golden Syrian hamster (Mesocricetus auratus)
cheek pouch model was chosen for this study because it consists of keratinized squamous
epithelium, collagen, skeletal muscle, blood vessels, adipose tissue, sebaceous glands, and other
representative tissue constituents.126 Imaging in an animal model allows in vivo and ex vivo
imaging to be performed on the same tissue specimen, enabling direct investigation of ex vivo
handing protocol on image characteristics. In addition, the hamster cheek pouch carcinogenesis
sequence closely resembles the events involved in the development of premalignant and
malignant human oral cancers,11 9 and is thus a relevant model for investigations of tumorigenesis
using optical techniques. Hamsters were anesthetized using intraperitoneal pentobarbital sodium
50 mg/kg with diazepam 10 mg/kg and kept warm using an isothermal heating pad (Braintree
Scientific, Braintree, MA) during the in vivo portion if the imaging procedures.
Prior to imaging, the anesthetized hamster cheek pouch was everted using a specially-designed
and fabricated clamp which was fastened rigidly to the optical table surface. Figure 3.1 shows a
photograph of the in vivo and ex vivo imaging set-up. The clamping device consisted of a top
aluminum piece with a window which enabled imaging and irrigation of the tissue surface and a
bottom plastic piece which enabled the periphery of the cheek pouch specimen to be pinned post-
mortem. In vivo imaging was initially performed. The animal was subsequently euthanized and
the zero time point was recorded at the time of cessation of respiration. The periphery of the
cheek pouch was then pinned to the bottom piece of the clamp, enabling the cheek pouch to be
excised from the animal with minimal disturbance to the in vivo imaging plane. Specimens of
approximately 1 cm x 1 cm size were used in this study to minimize the effect of changes in
optical scattering induced by loss of local supporting tissue structure. A custom-designed and
fabricated containment well was subsequently fixed around the clamp and the specimen was
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immersed in 10% neutral-buffered formalin (Fisher Scientific Co., Agawam, MA), isotonic
phosphate-buffered saline (OmniPur, EMD Chemicals Inc, Gibbstown, NJ), or Dulbecco's
Modified Eagle's Media (Gibco/Invitrogen, Carlsbad, CA). All preservation solutions were
refreshed every 15-20 minutes to maintain solution tonicity. Imaging was performed at room
temperature (21-23 deg C) to approximate the conditions present in most laboratory settings.
Imaging using PBS solution was additionally performed at body temperature (37 deg C using an
isothermal heating pad) and using an ice bath (solution temperature 8 deg C) to investigate the
temperature dependence of tissue preservation over time.
Figure 3.1: Photograph of the in vivo and ex vivo imaging set-up. The custom-built clamping
device consisted of a top aluminum piece with a window which enabled in vivo imaging and a
bottom plastic piece which allowed the periphery of the cheek pouch specimen to be pinned post-
mortem for accurate registration during the imaging timecourse. A custom-designed and fabricated
container fixed around the specimen enabled complete immersion of the excised specimen in
preservation solution.
Imaging protocol
Separate animals were used for each solution and temperature investigated in this study in order
to enable registered imaging in vivo and ex vivo over the entire time course. Imaging on an
additional animal was performed for DMEM solution preservation in order to verify consistency
of the observed results. For each solution, imaging was performed in vivo, at 15 min, 30 min, 1
hr, 1.5 hours, 2 hours, 2.5 hours, 3 hours, 3.5 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours,
and 10 hours. Imaging formalin solution was additionally performed at 12, 14, 16, and 18 hours
in order to insure complete fixation. For each imaging time point, eleven images were taken. The
first ten images were each sequentially offset in the sagittal direction by 100 pm, enabling
imaging over a tissue volume of 1 mm x 1 mm x 1 mm in dimension. This allowed
representative images over a cross-section of architectural morphology of the hamster cheek
pouch to be acquired and also to facilitated subsequent registration with histology. The final
image was taken in the same location as the first image to verify the accuracy of the registration
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protocol and to determine if contrast had changed over the course of the imaging procedure
itself. Each set of 11 images was acquired in approximately 10 minutes. After completion of the
imaging time course, the OCT imaging plane was marked with two microinjections of ink,
placed in 10% neutral-buffered formalin, routinely processed and paraffin embedded. Multiple 5
pm thick tissue sections were obtained from the OCT imaging planes and stained. Standard
Hematoxylin-Eosin as well as Masson's Trichrome stains were used to visualize the imaged
tissues for light microscopy. OCT images and corresponding histology sections were compared.
Minor discrepancies between histology and OCT images can be attributed to residual tissue
fixation, processing and sectioning artifacts.
RESULTS
OCT images and histology photomicrographs at 100x and 200x magnification are shown scaled
with the same magnification as the OCT image. All OCT images were scaled in the axial
direction by 1.38x to account for the approximate index of refraction of tissue.'0 2
10% Neutral-buffered formalin
A magnified view of the cheek pouch in vivo and at 18 hours with Hematoxylin and Eosin and
Masson's trichrome histology is shown in Figure 3.2. One-to-one correlation clearly identified
the keratinized squamous epithelium, lamina propria, skeletal muscle bundles, blood vessels,
adipocytes, and collagen-rich connective tissue. In vivo, the epithelium appeared uniformly
scattering. Muscle bundles appeared low scattering relative to highly scattering intervening
connective tissue. Collagen layers appeared relatively high scattering. Adipose tissue appeared
low scattering, with clearly septated borders between individual adipocytes. Intravascular
leukocytes in the blood vessel were seen in the OCT image as focal spots of increased scattering.
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Figure 3.2: Magnified view of the cheek pouch in vivo (A) and at 18 hours (B) with Hematoxylin
and Eosin (C) and Masson's trichrome (D) histology. One-to-one correlation clearly identified
structures corresponding to the epithelium (e), lamina propria (1p), superficial muscle layer (ml),
blood vessel (v), adipocytes (a), collagen-rich connective tissue (c), and deep muscle layer (m2).
Leukocytes appear in the OCT image as focal spots of increased scattering. (Wavelength 800 nm,
Resolution 1.5 pm axial x 5 pm transverse)
Figure 3.3 illustrates a sequence of representative OCT images acquired in vivo and over 16
hours in 10% neutral-buffered formalin. During the fixation process, change in contrast was
visible within the squamous epithelial layer itself, with an increase in scattering signal in the
lower 1/3-1/2 of the epithelium nearer the basal boundary (Figure 2, inset). Decrease in
scattering within the lamina propria was apparent, whereas scattering within muscle bundles
appeared to increase. Overall contrast between tissue architectural features appeared to increase
during fixation over 18 hours and corresponded in time with significantly noticeable tissue
shrinkage. Shrinkage was visible in the deeper muscle bundle and connective tissue layers by 1
hour after immersion in formalin and increase in scattering was significantly noticeable by 2
hours. The squamous epithelial layer, loose connective tissue, and muscle layers exhibited
approximately 50% overall shrinkage. Little or no shrinkage was observed in adipose tissue,
however, boundaries between adipocytes sharpened over the 18 hour time course. Shrinkage and
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distortion of the surrounding connective tissue is most likely responsible for visible architectural
changes in the adipose tissue layers. A large blood vessel visible at the center of the image also
exhibited shadowing in vivo and over the first 2 hours which disappeared completely by 4 hours.
A representative video showing the time course of formalin fixation is available in supplemental
material. The video shows sequential ultrahigh resolution OCT images acquired at each of the
imaging time points from in vivo to 18 hours.
Figure 3.3: Sequence of representative OCT images acquired in vivo and over 16 hours in 10%
neutral-buffered formalin: A, In vivo; B, 30 minutes; C, 1 hour; D, 2 hours; E, 4 hours; F, 8 hours;
G, 12 hours; H, 16 hours. Shrinkage was visible in all tissue layers. e: epithelium; ip: lamina
propria; ml, m2: muscle layers; c: connective tissue; a: adipose tissue; v: blood vessel. Tick marks
represent 250 pm. (Wavelength 800 nm, Resolution 1.5 pm axial x 5 pm transverse)
Isotonic phosphate-buffered saline (PBS)
Figure 3.4 illustrates OCT images acquired in vivo and over 6 hours after excision and
immersion in isotonic phosphate-buffered saline at room temperature. Appearance of tissue
architectural features in vivo was consistent with the in vivo appearance of the formalin
timecourse specimen discussed previously. However, post-excision optical scattering intensity
appeared to decrease monotonically after immersion in PBS. Decrease in overall signal intensity
was visible in the image within 30 minutes after tissue excision and was significant by 2 hours.
Loss of scattering signal appeared first in the deeper muscle and connective tissue layer (m2) and
was consistently noticeable within 3-4 hours. Swelling in the superficial muscle (ml) and thick
connective tissue layer (c) was visible. Settling of blood vessel contents was also visible, as was
some collapse of vessel walls. Significant overall changes in the epithelial layer were not
observed during immersion in isotonic PBS at room temperature over the 10 hour timecourse,
although shrinkage is visible in the histology due to formalin fixation.
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Figure 3.4: Sequence of representative OCT images acquired in vivo and over 6 hours in isotonic
phosphate-buffered saline solution at room temperature: A, In vivo; B, 30 minutes; C, 1 hour; D, 2
hours; E, 3 hours; F, 4 hours; G, 6 hours; H, Masson's trichrome. Loss of scattering signal was
significant within 2 hours and appeared to decrease monotonically after tissue excision. Swelling
in the muscle (ml and m2) and thick connective tissue layer (c) was visible. e: epithelium; lp:
lamina propria; v: blood vessel. Tick marks represent 250 pm. (Wavelength 800 nm, Resolution
1.5 pm axial x 5 pm transverse)
Figure 3.5 illustrates images acquired in vivo and at 6 hours post-excision obtained after
immersion in PBS at body temperature, room temperature, and under hypothermic conditions.
Each of the separate tissue specimens exhibited loss of scattering signal in the deeper muscle and
connective tissue layer (m2) by 3-4 hours which were significantly noticeable by 6 hours. Tissue
maintained at body temperature in PBS saline seemed to preserve higher signal intensity in the
deeper muscle layers relative to PBS at room temperature and using an ice bath, although
differences were not significant. Some swelling of the superficial muscle layer (ml) and thick
connective tissue layer (c) was observed at all temperatures.
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Figure 3.5: Images acquired in vivo (A,C,E) and at 6 hours (B,D,F) post-excision obtained after
immersion in PBS at body temperature (top), room temperature (middle), and under hypothermic
conditions (bottom). Tissue maintained at body temperature in PBS saline seemed to preserve
higher scattering signal intensity in the deeper tissue layers relative to PBS at room temperature
and using an ice bath, although differences were not significant. e: epithelium; lp: lamina propria;
ml, m2: muscle layers; c: connective tissue; v: blood vessel. (Wavelength 800 nm, Resolution 1.5
pm axial x 5 pm transverse)
Dulbecco's Modified Eagle's Media (DMEM)
Figure 3.6 illustrates OCT images acquired in vivo and over 10 hours after excision and
immersion in DMEM at room temperature. Visualization of tissue architectural morphology in
vivo was also consistent with in vivo imaging for both formalin and PBS specimens discussed
previously. Scattering signal intensity was maintained close to in vivo conditions during
immersion in DMEM up to 4-6 hours after excision. Slight decrease of scattering signal visible at
the 6-8 hour time point also appeared first in the deep muscle and connective tissue layer (m2),
but was not significantly noticeable until 8-10 hours after tissue excision. No significant overall
swelling in any of the tissue layers was observed during immersion in DMEM at room
temperature. Significant changes in the epithelial layer were not observed during immersion in
DMEM at room temperature over the 10 hour timecourse, although shrinkage is again visible in
the histology due to formalin fixation. Preservation in DMEM maintained the most similar image
appearance and overall signal intensity compared with in vivo imaging.
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Ice Bath
Figure 3.6: Sequence of representative OCT images acquired in vivo and over 10 hours in DMEM
solution at room temperature: A, In vivo; B, 30 minutes; C, 2 hours; D, 4 hours; E, 6 hours; F, 8
hours; G, 10 hours; H, Masson's trichrome. Optical scattering characteristics were maintained
close to in vivo conditions up to 4-6 hours after excision and remained similar over the entire
timecourse. e: epithelium; lp: lamina propria; ml, m2: muscle layers; c: connective tissue; v:
blood vessel. Tick marks represent 250 pm. (Wavelength 800 nm, Resolution 1.5 pm axial x 5 pm
transverse)
Figures 3.7 and 3.8 show a comparison of representative axial scan profiles for DMEM and PBS
in vivo, at 4 hours, and at 10 hours. Scan profiles were averaged over 10 consecutive axial scans
to minimize fluctuations due to noise. Axial scan profiles for PBS show loss of signal intensity
between layers over the time course and decrease in overall reflectivity, particularly in the deep
muscle and connective tissue layers. Overall tissue scattering signal was best preserved similar
to in vivo conditions using DMEM.
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Figure 3.7: Measured reflectance profiles as a function of depth for PBS in vivo, at 4 hours, and at
10 hours. Profiles were averaged over ten consecutive axial scans to reduce noise fluctuations.
Scan profiles for PBS show loss of contrast between layers over the timecourse and decrease in
overall signal intensity, particularly in the deep muscle and connective tissue layers. e: epithelium;
lp: lamina propria; ml, m2: muscle layers; c: connective tissue.
Dulbecco's MEM
In vivo 3 hours 6 hours
S- -- - - - - - s- ....... .-m i -
C
-- ] ....... C.... 40 ......
c c
m2 m2 Im
.20 .0
10 0. 10 --
0 1 200 300 40 600 a0 70 0 100 200 300 40 600 600 70 0 100 100 300 40 600 600 700
Depth [um] Depth [uM) Depth [uM]
In vim 3 hrS 6rs
Figure 3.8: Measured reflectance profiles as a function of depth for DMEM in vivo, at 4 hours,
and at 10 hours. Profiles were averaged over ten consecutive axial scans to reduce noise
fluctuations. Overall contrast and scattering signal intensity for DMEM was preserved similar to
in vivo conditions. e: epithelium; lp: lamina propria; ml, m2: muscle layers; c: connective tissue.
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DISCUSSION
Ex vivo investigations are often a necessary step in the process of validating new technologies
and devices for clinical applications. Ex vivo imaging has the advantage of allowing careful
control of imaging parameters and enabling accurate registration of images with histology and
allowing feasibility for future in vivo studies to be established.
As it is not always possible in human studies to image specimens immediately after excision, the
impact of post-excision imaging time and specimen handling protocol needs to be assessed in
order to minimize deviation of tissue ex vivo optical scattering properties from those observed in
vivo. Effects of ischemia, such as cell lysis, alter tissue microstructure and therefore could affect
optical scattering and imaging contrast. In addition, standard post-excision fixation and paraffin-
embedding may result in processing artifacts which can complicate image interpretation.
The objectives of this study were to investigate the effect formalin fixation on imaging using
optical coherence tomography, and test the effectiveness of two commonly available laboratory
solutions for ex vivo preservation of optical scattering over time. Accurate registration of images
with histology is particularly difficult to achieve with in vivo imaging. Prior studies have relied
on animal models using architectural landmarks to interpret tissue structures. 127 Imaging through
the fixation process minimizes artifacts introduced by fixation and allows one-to-one correlation
of tissue structures with histology, enabling direct interpretation of in vivo tissue architectural
features.
In this study, the formalin fixation process was seen to lead to changes in scattering and tissue
architectural distortion due to shrinkage of epithelial, muscle, and connective tissue layers. This
is consistent with results reported for human colorectal resection specimens.128 Formalin solution
is hyperosmotic relative to tissue, therefore shrinkage and scattering changes visible in OCT
images may be due to tissue dehydration. Recent studies investigating the effect of hyperosmotic
agents have shown that local dehydration may contribute to increased scattering due to greater
packing of inter- and intracellular tissue components which contribute to scattering. 113, 115, 129 In
addition, the extensive cross-linking of tissue proteins by formalin changes the tissue
microstructural features and may also result in changes in tissue optical scattering properties.
Changes in scattering during fixation therefore likely results from a combination of alterations in
tissue structural properties due to the fixation process and overall tissue dehydration. Although
significant distortion was evident during the fixation process, comparison of OCT images of
fixed specimens with histology showed that little cumulative structural artifact was introduced
during subsequent processing and sectioning.
Tissue preservation in PBS solutions resulted in gradual loss of tissue scattering intensity over
time, with some appearance of swelling in the superficial muscle and thick connective tissue
layer. Although significant changes in optical scattering characteristics were initially expected
within 30 minutes, pronounced changes in PBS were not evident until 2 hours after tissue
excision. Loss of scattering signal was most evident in the deep muscle and connective tissue
layer. In contrast, preservation in DMEM solution yielded only slight loss of overall scattering
signal over the entire time course and little tissue shrinkage or swelling. For both solutions, little
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overall change was visible in the keratinized squamous epithelial layer over the entire
timecourse. These results are consistent with examination of histology specimens from PBS and
DMEM solutions. Histology from PBS solutions showed evidence of mild to moderate edema of
the underlying connective tissue stroma which was not evident in histology from DMEM
solution. It is therefore possible that tissue edema is the dominant effect resulting in decreased
optical scattering. The osmolarity of PBS (~308 mOsm) is somewhat lower than that of DMEM
(-366 mOsm), therefore hydration and swelling is more likely during immersion in PBS
solution. No post-mortem autolysis was observed in any of the specimens, although evidence of
subtle cellular changes in the epithelium, such as mild to moderate intracellular edema and
swollen nuclei with open chromatin, was present which could reflect the effect of the
preservation solutions.
Tissue preserved at body temperature in PBS saline seemed to maintain slightly higher signal
intensity in the deep muscle and connective tissue layers relative to PBS at room temperature and
using an ice bath, although differences were not significant. In vivo tissue scattering
characteristics were expected to be best preserved using an ice bath because cryopreservation is
known to slow metabolic processes which result in accumulation of metabolic wastes and hasten
tissue autolysis. Lack of a significant effect of temperature on optical scattering over time
suggests that inherent cellular metabolic processes did not significantly contribute to visible
architectural changes within the investigated 10 timecourse. This is consistent with histology
from the specimens, which showed no significant differences between tissue specimens
maintained at different temperatures. It is also possible that changes in tissue scattering
characteristics were not dramatic post-excision because the hamster cheek pouch is relatively
robust and less sensitive to autolytic processes. Tissues with more fragile morphology, such as
gastric cardia or colonic mucosa, may experience faster post-mortem tissue degradation and be
more sensitive to ex vivo handling protocol.
The relative scattering intensity of tissue layers was consistent for all solutions both in vivo and
ex vivo over the imaging timecourse for both PBS and DMEM solutions. The squamous
epithelium was observed to be uniform and relatively low scattering compared to the underlying
lamina propria, and collagen and loose connective tissues were more highly scattering than the
muscle bundles. These observations are similar to results reported in vivo and ex vivo for human
esophagus, which consists of a uniform and lower scattering non-keratinized squamous
epithelium, a lower scattering muscularis layer, and higher scattering collagen-rich lamina
propria and submucosa.67' 71, 111 Discrepancy between in vivo and ex vivo layer thicknesses have
been observed which were attributed to specimen stretching and pinning artifacts, but may also
have included shrinkage due to fixation.'"
In this study, the focus zone of the image was held consistently 200-250 um below the surface of
the tissue. This enabled comparison between images, but depth of field limitations may lead to
different appearances of layers with the same tissue constituents. For example, the connective
tissue of the lamina propria in the hamster cheek pouch appears with noticeable fine structure,
while the thick connective tissue layer deeper in the tissue appears as a more uniformly
scattering band. This may be partially due to different tissue morphology and composition. It is
likely that focus tracking methods86, 130 would yield a more consistent appearance of tissue layers
in OCT images.
41
CONCLUSION
Ultrahigh resolution OCT consistently identified the normal keratinized squamous epithelial
layer, lamina propria, collagen and muscle bundles, blood vessels, and adipose tissue in vivo and
ex vivo. Formalin fixation can result in significant shrinkage of all tissue layers, resulting in
tissue architectural distortion. Imaging through the fixation process allowed one-to-one
correlation of hamster cheek pouch structures with histology, enabling accurate interpretation of
in vivo tissue architectural features. Changes in optical scattering were significant within the first
2 hours post-excision after preservation with isotonic PBS. DMEM best preserved in vivo tissue
scattering characteristics over the 10 hour imaging time course. While neoplastic lesions were
not evaluated in this study, it is expected that similar benefits of imaging using DMEM or other
tissue culture media would apply. Preservation at body temperature using PBS seemed slightly
better than either room temperature or cold preservation, although differences were not
significant. These results suggest that a tissue culture environment is preferable for preparation
of recently excised tissue specimens for optical imaging. These results can also be used as a
baseline to aid interpretation of tumor progression studies in the hamster cheek pouch model
using optical methods.
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Chapter 4
Ultrahigh Resolution Imaging of the Thyroid Gland using
Optical Coherence Tomography
INTRODUCTION
Current technologies available for imaging the thyroid gland include scintigraphy,
ultrasonography, computerized tomography (CT) and magnetic resonance imaging (MRI).
Nuclear scintigraphy, employing radioisotopes, provides mainly functional information about the
thyroid gland. The other non-isotopic, cross-sectional imaging techniques are better at providing
adjunctive anatomic information. These imaging methods, however, only have limited utility in
the evaluation of the thyroid gland. This is because none of these modalities have proven useful
in differentiating between benign and malignant thyroid nodules that require surgical
excision.3-133
An imaging modality capable of imaging the architectural morphology of the thyroid gland with
high-resolution on the micron scale could considerably improve the evaluation and management
of patients with thyroid abnormalities, as well as reduce the number of patients requiring
hazardous surgical exploration. Typical clinical ultrasound systems using sound wave
frequencies in the ten megahertz (10 MHz) range can yield spatial resolutions as fine as 150 Rm.
Even high-frequency ultrasound (30 MHz) devices, which have a maximal resolution of I10 Pm,
are insufficient to identify epithelial or other microstructure.4 In contrast, optical coherence
tomography (OCT), an emerging technology for in vivo high-resolution biomedical imaging, can
achieve resolutions in the cellular and even subcellular range (1 - 15 pm).3,4,8 6 ,135-137
The chapter explores the capability of OCT for imaging the human thyroid gland. Thyroid glands
containing normal and pathologic tissue were scanned ex vivo at a micron-scale resolution,
higher than has been accomplished by any available clinical imaging technology. OCT images
obtained were correlated with histopathology from corresponding areas to confirm tissue
identity.
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METHODS
Ultrahigh Resolution OCT Systems and Imaging Parameters
In this study, OCT imaging was performed using a portable, ultrahigh-resolution imaging system
and a surgical imaging probe. Ultrahigh resolution OCT imaging was performed with 4.5 pm
axial resolution in tissue using a compact femtosecond Cr:Forsterite laser light source.94 This
source operates at a center wavelength of 1260 nm with a 180 nm bandwidth. The 1260 nm
wavelength used is close to a minimum in tissue absorption and scattering, thus allowing
imaging to be performed up to 2-3 mm depths. The transverse spot size was set to ~11 Pim full
width half maximum (FWHM), a factor of 1.5-2x finer than standard OCT systems. The depth
of field was calculated to be -400 pm. Imaging was performed using an imaging probe (~I cm x
15 cm diameter x length) with a Hopkins lens relay system and beam scanning using
galvanometer mirrors, enabling real time visualization and adjustment of the OCT imaging
plane.
Preliminary studies were also performed using a portable ultrahigh resolution OCT system with
3.5 pm axial resolution in tissue. This OCT system used a femtosecond Nd:Glass laser light
source at a center wavelength of 1090 nm with ~150 nm bandwidth. 96  This laser is
commercially available (High Q Laser Productions, Hohenems, Austria) and is compact, robust,
and turnkey, making it suitable for future clinical studies. Although shorter wavelengths are
attenuated more rapidly by tissue scattering, they enable finer axial resolutions for a given
bandwidth as well as smaller spot sizes. The transverse spot size for this system was set to be -6
pm (FWHM) to examine the effects of improved transverse resolution on imaging the thyroid
gland. The depth of field was calculated to be -140 pm. OCT imaging was performed for this
system using post objective scanning in order to avoid aberrations and preserve the small spot
size.
Three-dimensional OCT imaging was also performed at 1.1 pm wavelengths. Three-
dimensional data sets consisting of 200 to 350 individual OCT images spaced by 3 pm apart
were generated by raster scanning the beam. Each OCT image in the raster scan consisted of
600-1800 transverse pixels over 1-2 mm. This resulted in an axial scan spacing of 0.6-3 Pm by 3
pm. The 3D OCT data was processed and visualized using MRI software for 3D visualization
and volume modeling (Amira, Mercury Computer Systems, Berlin).
Tissue Specimens
Studies were performed on post-mortem and freshly excised surgical thyroid specimens that
were received in the Beth Israel Deaconess Medical Center pathology laboratory. Three adult
thyroid glands were removed at autopsy and imaged within two hours of excision. Two post-
mortem thyroid glands were entirely normal and one gland had an incidental papillary
carcinoma. Fifteen thyroid gland specimens surgically excised from adult patients (median age
50 years; 13 female and 2 male) were imaged. Seven cases of multinodular goiter were imaged.
These goiters were comprised of multiple thyroid nodules ranging in size from 0.3 cm to 3.5 cm,
and were admixed with areas of cyst formation, hemorrhage, scarring and dystrophic
calcification. Three other specimens with benign solitary nodules measuring up to 1.9 cm in
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diameter were evaluated. Three adenomas, one (1.7 cm) with a predominant microfollicular
growth pattern and two (1.5 cm and 3.1 cm) with Hdrthle cell changes, were imaged. Two
surgical specimens containing papillary carcinoma (both follicular variants), measuring up to 2.2
cm were also imaged. Lymphocytic thyroiditis was noted in two thyroid glands. Preliminary
studies at were also performed at 1.1 pim wavelengths on five additional fresh surgical thyroid
specimens with goiter, microfollicular adenoma, Hirthle cell changes, and papillary carcinoma.
Grossly normal and scarred areas as well as nodular and cystic lesions were imaged.
Registration
Since the OCT source light was in the near infrared range and invisible to the naked eye, tissue
registration was performed with a visible green light guiding beam. When necessary, irrigation
of specimens (isotonic saline or RPMI 1640) was used to prevent dehydration during imaging.
Specimens were marked with India ink to designate the plane of OCT imaging. The samples then
underwent routine histologic processing. Tissue sections were placed in 10% formalin, routinely
processed and paraffin embedded. Multiple tissue sections of 5 pm thickness were obtained and
stained with Hematoxylin & Eosin. Samples were sectioned in the same plane as the scanning
plane. Digital two-dimensional OCT images and histology sections corresponding to the imaged
areas were compared to identify the sources of tissue contrast in the OCT images. Minor
observed discrepancies between histology and OCT imaging were attributed due to tissue
fixation, processing and sectioning artifacts.
RESULTS
Histology at 40x and 1 00x magnification are shown with corresponding size scale bars. All OCT
images correlated well with histopathology. Ultrahigh resolution OCT imaging results at 1.3 pm
wavelengths with 4.5 pm axial resolution and -11 pim spot size are presented first.
Normal thyroid microstructure was clearly visualized using OCT. Individual follicles with
lumens containing colloid could be identified (Figure 4.1). The smallest follicle visible measured
15 pm in greatest dimension. In normal thyroid glands the follicles were found to be round to
oval in shape, with only occasional focal irregularities noted. Colloid appeared low scattering,
and occasional follicles contained colloid with focal regions of high scattering. Normal follicular
epithelium appeared as a thin, highly scattering, dark layer lining larger follicles and as a slightly
thicker, dark rim around smaller follicles.
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Figure 4.1: Left, Normal thyroid tissue imaged ex vivo showing multiple colloid-filled follicles.
Right, Histology, Hematoxylin and Eosin 40x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x
11 pm transverse)
Focal benign papillae and smaller follicles (Sanderson's polsters) were found protruding into the
lumen of some follicles (Figure 4.2). The normal intervening connective tissue stroma was
homogeneous and contained identifiable blood vessels. Areas of recent hemorrhage were noted
to be highly backscattering. A dense outer capsule of the normal thyroid gland, measuring up to
150 gm in thickness, was imaged without difficulty and found to include focal clear adipose
tissue.
Figure 4.2: Left, Thyroid follicles showing a small intraluminal Sanderson's polster (arrow).
Right, Histology, Hematoxylin and Eosin 100x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x
11 pm transverse)
In all cases of multinodular goiter, OCT delineated multiple nodules comprised of mixed macro-
and micro-follicles lined by a flattened epithelium. Incomplete fibrous septae demarcating many
of these nodules were evident (Figure 4.3).
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Figure 4.3: Left, Fibrous capsule containing blood-filled vessels (arrow) seen demarcating a
mixed macro- and microfollicular thyroid nodule within a multinodular goiter. Right, Histology,
Hematoxylin and Eosin 40x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
Large cysts were readily identified (Figure 4.4).
Figure 4.4: Left, Large colloid-filled cyst (C) with adjacent compressed follicles. Right,
Histology, Hematoxylin and Eosin 100x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x 11 pm
transverse)
Specimens containing solitary benign hyperplastic nodules were also shown to contain both
macro- and micro-follicles. Scattered aggregates of lymphocytes identified between follicles in
cases diagnosed with lymphocytic thyroiditis were observed. A dense fibrous capsule was
visualized around two of the adenomas. Adenomas consisting predominantly of microfollicles,
averaging 90 gm in greatest diameter, were distinct in the OCT images (Figure 4.5). Even small
abortive follicles could be recognized. Many of the follicles present within adenomas were oval
in shape. Regions containing areas of trabecular and solid follicular growth patterns within
adenomas were also recognized (Figure 4.6).
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Figure 4.5: Left, Thyroid adenoma comprised of a predominantly microfollicular growth pattern.
Right, Histology, Hematoxylin and Eosin 100x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x
11 pm transverse)
Figure 4.6: Left, OCT image of adenoma with areas showing trabecular (T) and solid (S) growth
patterns. Right, Histology, Hematoxylin and Eosin 40x. (Wavelength 1.26 pm, Resolution 4.5 pm
axial x 11 pm transverse)
The follicular epithelium in H rthle cell adenomas was shown to be more highly scattering, and
also formed a thicker (up to 30 pm) lining around follicles (Figure 4.7), compared to normal
follicles. Many closely packed follicles ranging in size from 15 gm to 45 pm were seen in the
follicular variant papillary carcinomas. Areas of dense fibrous scarring in these malignant
nodules, often with entrapped malignant follicles, were also found.
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Figure 4.7: Left, OCT image of Hfirthle cell adenoma. Note the thick backscattering layer of
abundant granular appearing oncocytic epithelium lining follicles. Right, Histology, Hematoxylin
and Eosin I00x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
Such entrapped malignant follicles were markedly irregular, often with jagged edges (Figure
4.8). Finally, calcification (Figure 4.9) and even ossification were distinguished using OCT, and
did not prevent tissue imaging.
Figure 4.8: Left, OCT image of sclerosing papillary carcinoma. Irregular malignant follicles are
entrapped in dense scar tissue. Right, Histology, Hematoxylin and Eosin 40x. (Wavelength 1.26
pm, Resolution 4.5 pm axial x 11 pm transverse)
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Figure 4.9: Left, Optical coherence tomography image of dystrophic calcification (Ca) adjacent to
an area of dense (S) scar tissue. Right, Histology, Hematoxylin and Eosin 100x. (Wavelength
1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
Preliminary studies using ultrahigh resolution OCT imaging was also performed at 1.1 pm
wavelengths with 3.5 pm axial resolution and -6 pm spot size. This represents a -25% finer
axial resolution and a 2x finer transverse resolution than the previous study. Figure 4.10 shows
an example image of thyroid goiter. The follicular cell layer lining individual follicles is clearly
visible in the image. Epithelial features were more consistently visible in tissue specimens
imaged at 3.5 pm axial resolution and 6 pm spot size compared to 4.5 pm axial resolution and 11
pm spot size.
- 100 uM -- O-100 um
Figure 4.10: Left and center, Thryroid goiter imaged ex vivo using 1.1 pm wavelength and 6 pm
transverse resolution. The follicular epithelial layer lining individual follicles can be clearly
distinguished. Right, Histology, Hematoxylin and Eosin 100x. (Wavelength 1.09 pm, Resolution
3.5 pm axial x 6 pm transverse)
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Figure 4.11: Preliminary OCT images of thyroid cancers at 1.1 pm wavelength and 6 pm
transverse resolution. Left, Papillary tumor. Right, Solid tumor. Bottom left and right: Histology,
Hematoxylin and Eosin 100x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 4.11 shows two preliminary images of thyroid cancers at 1.1 Pm wavelength and 6 Pm
transverse resolution. Epithelial lining appeared thickened in the papillary tumor. Microfollicular
structures could be clearly identified in the solid tumor.
Figures 12 and 13 show representative 3D OCT sequential en face views at different depths
beneath the surface of normal thyroid and papillary carcinoma. Three-dimensional imaging
allows tracking of features through multiple cross-sectional planes. Three-dimensional
information could allow accurate identification of tumor margins for interventional procedures.
Videos showing sequential en face slices through normal thyroid and papillary carcinoma are
available in the supplemental materials.
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Figure 4.12: Sequential rendered enface views of normal thyroid. The rendered volume consisted
of 330 transverse slices. Movies showing sequential en face slices are available in the
supplemental materials. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 4.13: Sequential rendered en face views of tumor region from the same patient. The
rendered volume consisted of 330 transverse slices. Movies showing sequential en face slices are
available in the supplemental materials. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm
transverse)
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DISCUSSION
Diseases involving the thyroid gland are common. Thyroid nodules, in particular, are a
diagnostic challenge frequently encountered in clinical practice. Approximately 4-7% of adults
have palpable thyroid nodules, and up to 50-70% can have nodules visible on thyroid
ultrasonography. 96 The prevalence of thyroid carcinoma in solitary or dominant nodules is only
about 5%. 138 In order to avoid unnecessary thyroidectomy, especially given the fact that thyroid
malignancies rarely cause death, it is important to be able to differentiate malignant from benign
nodules. However, none of the current imaging modalities can confidently distinguish benign
from malignant nodules. 3 2 The sensitivity of preoperative ultrasound diagnosis, for example,
was 86.5% for non-follicular neoplasms and 18.2% for follicular neoplasms in one study.139
Ultrasonography is capable of discriminating masses as small as 2 mm in the thyroid gland, and
has proven to be most useful in differentiating solid from cystic lesions. 4 0 However, even large
thyroid nodules with acoustic characteristics similar to normal thyroid tissue may be impossible
to distinguish by ultrasound. 3 2 Moreover, acoustic signals are blocked by calcification in the
thyroid. MRI permits thinner sections than CT with higher resolution, but at best can only detect
thyroid nodules as small as 3-5mm.13 2 Despite technical advances, the results of available thyroid
imaging modalities have been found not to correlate well with histopathologic findings.' 3 2
Because thyroid carcinoma cannot be distinguished from benign nodules using current imaging
techniques, fine needle aspiration cytology has become the primary diagnostic procedure in the
evaluation of patients with a thyroid nodule. However, both tissue biopsy and aspiration have
limitations. Only a limited amount of tissue is obtained which may not be representative of the
entire lesion. Biopsy is also not reliable in the diagnosis of follicular carcinoma, in which
evidence of capsular or blood vessel invasion is required for the diagnosis. The potential for
OCT to provide information about tissue microstructure, previously only obtained by
conventional biopsy, could greatly help in the evaluation of the thyroid gland.
In this study, OCT was used to image thyroid tissue ex vivo. These results demonstrate the
feasibility of this novel modality for clinical imaging of the thyroid gland. Individual thyroid
follicles on the order of 15 pm were easily resolved. This resolution is higher than any available
imaging technology of the thyroid gland. Normal thyroid follicles have an average diameter of
200 Pm.14 ' The ability to delineate individual follicles permits the growth pattern
(macrofollicular, microfollicular, mixed and solid) of thyroid tissue including nodules to be
determined. This conveys valuable information because lesions found to contain macrofollicles
are likely benign, whereas nodules comprised predominantly of microfollicles are more likely to
be neoplastic. Assessment of follicle shape may also provide valuable information. Normal
follicles are round to oval in shape. Elongate follicles are abnormal, suggesting hyperplastic or
neoplastic conditions, or could result from compression of an adjacent expanding mass. 4 2
OCT was able to identify the backscattering epithelial layer lining follicles. This epithelial lining
was found to be more prominent in lesions exhibiting oncocytic (Hiirthle) cell changes.
Improved resolution as shown in the preliminary imaging study at 1.1 Pm wavelengths
demonstrated that this epithelial lining could be more clearly visualized. Although not shown in
this study, it is possible that OCT may be able to distinguish flat to low cuboidal epithelium of
inactive follicles from columnar follicular cells of active follicles. Papillary projections into the
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lumen of large follicles were recognized. These are normally present in thyroid tissue, but may
be accentuated in hyperplastic conditions.142 Epithelial-lined papillae containing fibrovascular
cores, a feature of some papillary thyroid carcinomas, are therefore likely to be detected when
imaged using OCT. In the imaged thyroid specimens, colloid was easily identified, including
those follicles that contained debris and hemorrhage. The focal regions of high scattering visible
in the colloid of many follicles corresponded to the basophilic flocculent colloid clumps
normally found in thyroid tissue.139, 141, 142 OCT was also able to clearly image the intervening
connective tissue stroma, fibrous septae, capsules surrounding nodules and areas of degeneration
(hemorrhage, scarring, and cyst formation). This study also demonstrated ultrahigh resolution 3D
OCT imaging. 3D imaging and volume rendering provided complementary information to cross-
sectional OCT images, enabling visualization of arbitrary planes and rendering of surface
topography as well as subsurface tissue microstructure. The ability to visualize multiple imaging
planes enables the three-dimensional follicular organization to be assessed in a way not possible
using individual OCT images. No cases of follicular carcinoma were available to study. The
utility of 3D OCT for assessing capsular or vascular invasion using OCT was not investigated.
The superficial location of the thyroid gland makes it an easy structure to image clinically. The
major technical limitation of this study, however, is the fact that the micron-scale resolution we
achieved was limited to a depth of approximately 1.5 mm. At present, this would restrict the
clinical utility of OCT to the intraoperative setting, or would require insertion of an optical
imaging device into the thyroid gland. Because OCT is fiber optically based, imaging can be
performed inside solid tissues or organs using needles of 27 gauge or smaller.5 3 A needle based
OCT imaging device could image a cylindrical region of tissue measuring 6 mm in diameter and
several mm in length. OCT imaging can also be integrated with biopsy devices to guide
placement prior to excision of a specimen. Future developments currently underway to improve
the performance of OCT promise to yield further improvements in both resolution and contrast.
In vivo cellular level OCT imaging in embryology specimens has been achieved.143 The capacity
to identify individual cells and assess their nuclei may prove extremely useful in the assessment
of papillary thyroid carcinoma. Modem OCT systems, as employed in this study, are compact
and portable and can provide image acquisition rates in real time. Three-dimensional digital
image data sets can also be generated. Moreover, color Doppler OCT is now available, enabling
real-time flow velocity measurements to be obtained simultaneously with tissue structural
information.144' 145 This will allow the blood flow dynamics in thyroid lesions to be observed
simultaneously with micron-scale resolution cross-sectional imaging.
CONCLUSION
This chapter demonstrates for the first time that high-resolution cross-sectional imaging of
thyroid tissue using OCT is feasible. OCT images obtained correlate well with conventional
histopathology and has the potential to provide reliable and clinically useful information of
normal, benign and malignant thyroid tissue that until now has only attainable by conventional
histopathologic examination. These results suggest that this OCT may be a promising diagnostic
tool in the evaluation of patient's with thyroid disease, helping to better select patients with a
high risk of having a malignant lesion. Since the prognosis of thyroid cancer is partially
dependent on its size at surgery, earlier beneficial detection of cancer may be possible using
OCT as an adjunct to current imaging techniques.
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Chapter 5
Ultrahigh Resolution and Three-Dimensional OCT Imaging
of the Large and Small Intestine
INTRODUCTION
Colorectal cancer (CRC) is a common, lethal, and preventable disease. Approximately 146,000
new cases of colorectal cancer are diagnosed each year in the United States, and approximately
one in three people who develop CRC die of the disease. CRC ranks second only to lung cancer
as a cause of cancer death, accounting for 10 to 11% of cancer deaths overall, and it is third both
in frequency and in cause of cancer death in men and women separately. Despite these grim
statistics, the incidence rate of CRC has declined slightly by approximately 3% per year since
1998, and mortality rates have decreased by an average of 1.7% per year since 1989. These
declines have been attributed to both increased screening for and removal of polyps before they
progress to invasive cancer and improved treatment methods.2
The majority of colonic carcinomas are endoluminal, making them amenable to early detection
by means of endoscopy. There has therefore been significant interest in the development of
improved diagnostic techniques to detect early stage colorectal disease. Identification of high-
risk groups and endoscopic surveillance remains the best method for detecting early stage
malignancy. Early detection and treatment can improve survival rates to 90%.2 However,
detection of microscopic changes within the mucosa and submucosa is still currently beyond the
capabilities of routine endoscopic techniques. Recent analysis of missed lesions in the detection
of both gastric and colon cancers suggests that there exists a need for more accurate diagnosis of
non-polypoid mucosal lesions. 146' 147 Developments in endoscopic mucosal resection (EMR) as a
minimally invasive technique for treating early-stage gastrointestinal cancers has also lead to a
demand for improved endoscopic imaging for accurate staging of the depth of tumor invasion.
OPTICAL COHERENCE TOMOGRAPHY
Optical coherence tomography (OCT) is an emerging imaging modality which can generate
micron-resolution, cross-sectional images of tissue microstructure in situ and in real time.3,4,
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148 OCT can be incorporated into a wide variety of endoscopic and laparoscopic imaging
devices.' 5' "1 OCT has the advantage of enabling subsurface visualization of microscopic
mucosal and submucosal architectural features which are not visible using standard endoscopy.
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Early investigations of OCT imaging focused on ex vivo imaging of gastrointestinal tissues to
establish correlations with histopathology and feasibility for future endoscopic studies.
9
' 106-108, 117
With the development of fiber optic endoscopes, in vivo OCT imaging in animals was
demonstrated.5 1 Several groups have performed clinical endoscopic OCT imaging studies
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110, 149-153 Much of this clinical work has focused on the upper gastrointestinal tract, where
Barrett's esophagus, esophageal adenocarcinoma, and normal gastric cardia were visualized.
Excellent sensitivities and specificities were demonstrated for detecting Barrett's esophagus.72
OCT imaging can also be applied to the large and small intestine, such as for endoscopic
surveillance, detection, staging, and follow up of colorectal cancer. Recent work has shown that
OCT has potential to distinguish hyperplastic from adenomatous polyps in the colon and
suggests models for detecting dysplasia.73
Virtually all endoscopic studies to date have been performed with axial image resolutions of 10-
15 pm at 1.3 pm wavelengths. However, OCT technology is rapidly evolving and performance
has improved significantly. Standard OCT systems use superluminescent diode light sources
which are commercially available, compact and low cost, but have limited bandwidths and
wavelengths. For this reason, all previous endoscopic imaging studies had limited axial
resolutions of 10-15 pm at 1.3 pm wavelengths. In addition, most endoscopic imaging studies
used relatively low numerical aperture focusing, limiting transverse resolutions to -15-30 pm.
Using femtosecond laser light sources it is possible to achieve ultrahigh axial image resolutions
approaching -1-2 pm, a factor of -10x improvement over standard resolution OC86 87, 89, 92, 96
These femtosecond laser light sources also enable new wavelength ranges which are not
accessible by superluminescent diodes. Recently, ultrahigh resolution in vivo endoscopic OCT
imaging in an animal model has been demonstrated with an axial resolution of 3.7 Pim in tissue
using a 1.3 pjm wavelength femtosecond Cr:Forsterite laser light source.154
This chapter investigates new ultrahigh resolution OCT technology for imaging the large and
small intestine. In this study, normal, inflammatory, and neoplastic tissues of the large and small
intestine were imaged ex vivo and correlated with histology. Imaging was performed using
portable, ultrahigh resolution OCT systems in the clinical pathology laboratory. Imaging in the
pathology laboratory allows rapid access to surgical specimens, reducing possible artifacts from
tissue degradation. This method also enables accurate registration of OCT images with
histology, which is difficult to achieve in endoscopic OCT imaging.
Ultrahigh resolution OCT imaging at -1.3 pm wavelength was performed with 4.5 pm axial
resolution and 11 pm spot size using a compact Cr:Forsterite laser light source. This study
evaluates improved resolution using the standard OCT imaging wavelength of 1.3 Pm.
Complementary studies on a smaller set of specimens were performed at -1.1 Pm wavelength
with a 3.5 pm axial resolution and 6 pim spot size using a Nd:Glass laser light source. The
Nd:Glass laser has the important advantage of being compact and commercially available and is
therefore more suitable for future clinical endoscopic imaging studies. This system performs
imaging at wavelengths shorter than the wavelength typically used in OCT. The transverse spot
size was chosen to be small in order to improve transverse resolution. Finally, three-dimensional
OCT imaging was performed to investigate the utility of 3D visualization of tissue architectural
morphology. These studies are an important step toward developing new OCT technology for
56
future clinical endoscopic imaging applications and could help serve as a baseline for future
ultrahigh resolution endoscopic OCT studies.
METHODS
Ultrahigh Resolution OCT Systems and Imaging Parameters
The physical principles of OCT have been described previously. 3, 4 Cross-sectional images of
internal tissue microstructure are generated by scanning a beam of light on tissue and measuring
the echo time delay and magnitude of backscattered or backreflected light. OCT images are two-
dimensional data sets displayed as grey scale or false color images, representing the optical
backscattering or backreflection in a cross-sectional plane. Three-dimensional volume datasets
can be generated by combining a registered set of transverse OCT scans, allowing visualization
from different virtual perspectives and rendering of tissue architectural morphology.
This study investigates new ultrahigh resolution OCT imaging technology for imaging normal
and pathologic tissues of the large and small intestine and correlates images with histology. The
study has three parts. Ultrahigh resolution OCT imaging was performed with 4.5 Pm axial
resolution in tissue, a factor of 2-3x finer than standard endoscopic OCT systems. This OCT
system used a femtosecond Cr:Forsterite laser light source at a center wavelength of 1260 nm
with a 180 nm bandwidth. 94 The transverse spot size was set to ~11 pm full width half
maximum (FWHM), a factor of 1.5-2x finer than standard endoscopic OCT. The depth of field
was calculated to be ~400 pm. Imaging was performed using an imaging probe (~A cm x 15 cm
diameter x length) with a Hopkins lens relay system and beam scanning using galvanometer
mirrors, enabling real time visualization and adjustment of the OCT imaging plane. For
comparison with ultrahigh resolution OCT imaging results, imaging was also performed on a
specimen of normal colon using typical standard resolution OCT parameters at 1300 nm
wavelength with 12 pim axial resolution in tissue. Imaging was performed using a commercially
available superluminescent diode light source using equivalent system sensitivity parameters.
The transverse spot size was set to ~23 pm (FWHM), comparable to endoscopic OCT imaging
parameters. Imaging was also performed using a transverse spot size of -9 pm (FWHM) in
order to investigate the effect of improved transverse resolution at standard axial resolutions.
Ultrahigh resolution OCT imaging was also performed with 3.5 Pm axial resolution in tissue.
This OCT system used a femtosecond Nd:Glass laser light source at a center wavelength of 1090
nm with ~150 nm bandwidth.96 This laser is commercially available (High Q Laser Productions,
Hohenems, Austria) and is compact, robust, and turnkey, making it suitable for future clinical
studies. Although shorter wavelengths are attenuated more rapidly by tissue scattering, they
enable finer axial resolutions for a given bandwidth as well as smaller spot sizes. The transverse
spot size was set to be ~6 pm (FWHM) to examine the effects of improved transverse resolution.
This transverse spot size is a factor of 3-4x finer than standard endoscopic OCT. The depth of
field was calculated to be -140 pm. OCT imaging was performed using post objective scanning
in order to avoid aberrations and preserve the small spot size.
Three-dimensional OCT imaging was performed at 1090 nm wavelengths. Three-dimensional
data sets consisting of 200 to 350 individual OCT images spaced by 3 pm to 5 pm apart were
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generated by raster scanning the beam. A 5 pm spacing was chosen for specimens with large
architectural features and a 3 pm spacing was used for all other specimens. Each OCT image in
the raster scan consisted of 600-1800 transverse pixels over 1-2 mm. This resulted in an axial
scan spacing of 0.6-3 pm by 3-5 pm. The 3D OCT data was processed and visualized using
MRI software for 3D visualization and volume modeling (Amira, Mercury Computer Systems,
Berlin).
Specimen Imaging and Handling
Imaging studies were performed on freshly excised surgical specimens in the pathology
laboratory of the Beth Israel Deaconess Medical Center. These studies were approved by the
Institutional Review Board (IRB) at the Beth Israel Deaconess Medical Center and the
Committee for the Use of Humans as Experimental Subjects (COUHES) at the Massachusetts
Institute of Technology. Informed consent was not required since the study involved only
database review and ex vivo surgical specimens. Fresh specimens were selected based on the
presence of pathology upon gross examination, prompt arrival in the pathology laboratory, and
large specimen size, allowing normal and pathologic tissue to be collected from each specimen
for the study without interfering with routine diagnostic procedures. In selected cases,
specimens used for clinical diagnostic purposes were imaged immediately prior to placement in
cassettes for standard processing. Specimens experiencing excessive prior handling were
excluded from the study because of possible damage to the fragile mucosa. All specimens
available during the duration of the study which met these criteria were imaged. The study was
concluded when a representative set of normal specimens and common neoplastic pathologies
was obtained. The study duration was 4 weeks for the first part of the study imaging at 1.3 Pim
and 2 weeks for the second part of the study imaging at 1.1 pm wavelengths.
Normal and diseased intestinal tissues from surgical resections were imaged within three hours
of excision. A total of 65 sites from 23 surgical specimens from adult patients were imaged.
Both normal and pathologic sites from each specimen were imaged. Sites which had
experienced excessive handling, such as within 1-2 mm of the surgical margin of the specimen,
were not imaged. The majority of specimens were imaged with the 1.3 Pm wavelength OCT
system. Normal intestinal sites imaged in this first phase of the study included duodenum (n =
2), jejunum (n = 5), and colon (n = 11). Diseased tissue sites included inflammatory bowel
disease (n = 9; ulcerative colitis n = 8; Crohn's disease n = 1), and neoplasia (n = 6), with one
tubulovillous adenoma involving the duodenum, one submucosal lipoma, three sites of invasive
adenocarcinoma involving the colon, and one squamous cell carcinoma in the anorectal region.
A smaller set of specimens were imaged with the 1.1 pm wavelength OCT system. Sites imaged
in the second phase of the study included normal colon (n = 11), ulcerative colitis (n = 2), and
five sites of adenoma or invasive adenocarcinoma. Specimens with ulcerative colitis of varying
severity, ranging from minimal to severe inflammation and ulceration were imaged. Grossly
normal as well as ulcerated and scarred lesions (n = 14) were also imaged.
Since the OCT light was in the near infrared and invisible to the eye, image registration was
performed with a visible green guiding beam which was coincident with the OCT imaging beam.
Imaging was performed without contact to the tissue to prevent artifacts introduced from tissue
compression. All images were scaled in the axial direction by 1.38x to correct for the
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approximate index of refraction of tissue. When necessary, specimens were irrigated (isotonic
saline or RPMI 1640) to prevent dehydration during imaging. Specimens were marked at the
beginning and end of each OCT scan with microinjections of ink to designate the imaging plane
orientation. When necessary, after imaging and inking, specimens were immersed in Bouin's
fixative for 2 seconds to fix the ink and prevent smearing. Specimens were then placed in 10%
buffered formalin, routinely processed and paraffin embedded. Multiple 5 pm thick tissue
sections were obtained from the OCT imaging plane and stained with Hematoxylin and Eosin.
OCT images and corresponding histology sections were compared. Minor discrepancies
between histology and OCT images can be attributed to tissue fixation, processing and sectioning
artifacts.
RESULTS
OCT images and histology photomicrographs at 40x to 200x magnification are shown with
corresponding size scale bars. Histology is scaled with the same magnification as the OCT
image. Ultrahigh resolution OCT imaging results at 1.3 pm wavelengths with 4.5 pm axial
resolution and -11 pm spot size are presented first. This is 2-3x finer axial resolution and 1.5-2x
finer transverse resolution than previous ex vivo and endoscopic studies and imaging is at the
same wavelength as previous studies.
Imaging of normal colon produced distinct images of the mucosa and submucosa characteristic
of normal colonic microstructure. Figure 5.1 shows a representative ultrahigh resolution OCT
image of the normal colon and corresponding histology. OCT clearly visualized the full
thickness of the colon mucosa in almost all specimens. The submucosa appeared as a lighter and
less optically scattering layer. The muscularis mucosa appeared as a scattering band in the OCT
image separating the mucosa and submusoca. Although the epithelial layer and single crypts
were visible, they were not consistently visible in all images. Enhanced optical signal intensity
beneath individual crypt structures was observed and may be the result of increased transmission
of the light through the crypts.
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Figure 5.1: Left, Ultrahigh resolution OCT image of normal colon. Mucosa (M) is clearly
delineated from underlying submucosa (SM) by a scattering band corresponding to the thin
muscularis mucosa (arrows). The submucosa is visible as less optically scattering layer. Inset,
Magnified view of the OCT image. Right, Histology, Hematoxylin and Eosin 40x. (Wavelength
1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
In comparison, Figure 2A shows a representative OCT image of normal colon mucosa acquired
with typical standard resolution OCT imaging parameters at 1.3 pm wavelength, 12 pm axial
resolution, and 23 pm transverse resolution. Speckle was clearly visible at standard resolutions,
degrading overall image quality compared to the ultrahigh resolution OCT imaging in Figure 1.
Figure 2B shows a standard resolution OCT image acquired on the same specimen with identical
wavelength and axial resolution as Figure 2A, but with a further -2.5x improvement in
transverse resolution obtained by focusing to smaller spot sizes. Improving transverse resolution
reduced speckle, yielding notable improvement in image sharpness. However, ultrahigh
resolution OCT images with -2.5x improvement in both axial and transverse resolution enabled
visualization of the epithelial layer and fine structure in the mucosa. Imaging with improved
overall resolution significantly reduced image degradation due to speckle, improving image
quality.
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Figure 5.2: Left, OCT image of normal colon mucosa acquired using typical standard resolution
imaging parameters. Image degradation due to speckle is clearly evident. (Wavelength 1.3 pm,
Resolution 11.6 pm axial x 23 pm transverse) Inset left, Magnified view of the OCT image.
Right, OCT image of the same specimen acquired with ~2.5x improved transverse resolution.
(Wavelength 1.3 pm, Resolution 11.6 pm axial x 9 pm transverse) Inset right, Magnified view of
the OCT image.
Figure 5.3 shows a representative ultrahigh resolution OCT image of normal small intestine and
corresponding histology. Villi of varying sizes can be clearly distinguished in the OCT images.
The epithelial cell layer lining individual villi was also visible in the small intestine as a band
measuring 25-40 pm in thickness. The submucosa again appeared as a lighter and less optically
scattering layer.
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Figure 5.3: Left, Ultrahigh resolution OCT image of normal small intestine. Villi of varying sizes
can be distinguished. The epithelial cell layer (Ep) was visible as a thin scattering band 25-40 pm
in thickness lining individual villi. Mucus is visible between the villi in the images. Histology,
Hematoxylin and Eosin 100x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
Figure 5.4 shows a representative OCT image and histology of chronic ulcerative colitis. In mild
disease, a disrupted mucosal surface due to ulceration and erosion of the epithelium was visible.
With more severe disease, irregular and distorted glands characteristic of chronic inflammatory
bowel disease were evident. Markedly increased inflammatory cells within the supporting
lamina propria appeared as highly scattering. Figure 5.5 shows an image of Crohn's disease of
the colon. Abundant irregular branching glands are apparent in the OCT images and histology.
The dense inflammatory infiltrate in the lamina propria was again highly scattering. No cases
complicated by dysplasia were available to study.
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Figure 5.4: Ultrahigh resolution OCT image of ulcerative colitis showing a disrupted mucosal
surface due to ulceration and erosion, architectural distortion of glands, and increased scattering
due to chronic inflammatory infiltrate (I) in the lamina propria. Histology, Hematoxylin and Eosin
100x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
Figure 5.5: Left, Ultrahigh resolution OCT image of chronic colitis due to Crohn's disease
showing branching irregular glands and increased scattering due to dense inflammatory infiltrate
in the lamina propria. Inset, Magnified view of the OCT image. Right, Histology, Hematoxylin
and Eosin 40x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
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Figure 5.6 shows an OCT image and corresponding histology of adenocarcinoma. Figure 5.7
shows an OCT image and corresponding histology of invasive squamous carcinoma of the anus.
OCT images of both types of carcinoma revealed complete loss of normal mucosal architecture
and invasion of the submuscosa. Highly scattering and irregular invasive glands were visible in
OCT images of adenocarcinoma. Tongues of squamous epithelium in OCT images of squamous
cell carcinoma also appeared with increased scattering compared to surrounding regions, and
were seen to extend irregularly into the stroma. OCT images also showed areas with cysts and
ulceration with overlying fibrinopurulent exudate.
Figure 5.6: Left, Ultrahigh resolution OCT image of well-differentiated adenocarcinoma. Highly
irregular invasive glands are visible in a desmoplastic stroma. No clear boundary between mucosa
and submucosa is evident in this case. Right, Histology, Hematoxylin and Eosin 40x. (Wavelength
1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
Figure 5.7: Left, Ultrahigh resolution OCT image of invasive squamous cell carcinoma of the
anus with surface ulceration. Irregular tongues of malignant epithelium can be seen extending into
the underlying stroma (arrows). Right, Histology, Hematoxylin and Eosin 40x. (Wavelength 1.26
pm, Resolution 4.5 pm axial x 11 pm transverse)
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Figure 5.8 shows an OCT image and corresponding histology of a tubulovillous adenoma of the
duodenum. OCT images of tubulovillous adenoma also showed loss of normal mucosa
architecture with the formation of deep folds consistent with villous architecture. Regions of
high scattering intensity were observed in the epithelium of the tubular adenoma. Figure 5.9
shows an OCT image and corresponding histology of a well-circumscribed lipoma within the
submucosa. Adipocytes appeared clear and low scattering, with individual well-circumscribed
cell borders and intervening septae. Loss of the epithelium is evident in the histology and is the
result of processing artifacts.
Figure 5.8: Left, Ultrahigh resolution OCT image of a tubulovillous adenoma of the duodenum.
Loss of normal mucosal structure is apparent and architecture correlates well with histology. Inset,
Magnified view of the OCT image. Right, Histology, Hematoxylin and Eosin 40x. (Wavelength
1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
Figure 5.9: Left, Ultrahigh resolution OCT image of a submucosal lipoma (L). Adipocytes
appeared low scattering, with circumscribed borders of increased scattering. Erosion of the colon
mucosa is evident in the histology and is the result of processing artifacts. Right, Histology,
Hematoxylin and Eosin 20x. (Wavelength 1.26 pm, Resolution 4.5 pm axial x 11 pm transverse)
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Ultrahigh resolution OCT imaging was also performed at 1.1 pm wavelengths with 3.5 pm axial
resolution and ~6 pm spot size. This represents a 2-3x finer axial resolution and a 3-4x finer
transverse resolution than previous ex vivo and endoscopic studies. These studies use a Nd:Glass
laser which operates at shorter wavelengths than previous studies. However, lasers at this
wavelength are more readily available and suitable for future clinical use.
Figure 5.10 shows a representative OCT image and corresponding histology of normal colon at
1.1 pm wavelength with ~6 pm transverse resolution. The finer transverse resolution more
clearly delineates the individual crypt structures and the epithelial layer than images at 1.3 pm
wavelength. The epithelium is visible as a distinct layer, approximately 40-50 pm in thickness,
delineated by a thin, highly scattering band from the supporting lamina propria. Individual
crypts as well as the epithelial layer lining the crypts are visible. Enhanced scattering beneath
the individual crypts was also observed. Since a smaller focused spot size of ~6 pm was used in
the 1.1 pm wavelength studies, versus 11 pm in the 1.3 pm wavelength studies, the depth of
field is reduced. With the OCT beam focus set at ~100 pm below the surface, structures within
200-250 pm of the surface could be clearly resolved. Deeper structures were out of focus and
appeared lower scattering. The submucosa was therefore not visible in most specimens.
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Figure 5.10: Ultrahigh resolution OCT image of normal colon mucosa acquired at 1.1 pm
wavelength with 6 pm transverse resolution. The epithelial layer appeared as a distinct layer
approximately 40-50 pm in thickness, delineated from the supporting lamina propria by a thin
highly scattering band (arrows). Individual crypts as well as the epithelial layer (Ep) lining crypts
were visible. Increased scattering (s) possibly due to multiple-scattering effects was often seen
beneath crypt structures. Histology, Hematoxylin and Eosin 100x. (Wavelength 1.09 pm,
Resolution 3.5 pm axial x 6 pm transverse)
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Figure 5.11 shows a representative OCT image of ulcerative colitis and corresponding
histology. OCT images at 1.1 pm wavelength were comparable to 1.3 pm wavelength. A
disrupted mucosal surface due to ulceration and erosion of the epithelium and irregular
branching glands were visible. Crypt abscesses were also present and visible in some
specimens of ulcerative colitis. Areas of increased inflammatory cells as determined by
histology correlation also appeared highly scattering.
Figure 5.11: Left, Ultrahigh resolution OCT image of ulcerative colitis. A disrupted mucosal
surface due to ulceration and erosion and increased scattering due to chronic inflammatory
infiltrate was visible. Inset, Magnified view of the mucosal surface. Right, Histology,
Hematoxylin and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 5.12 shows an OCT image and corresponding histology of a polypoid adenoma of the
colon. The OCT images showed highly irregular glands and regions of high scattering intensity.
Individual cells were not visible, but increased scattering at the basal boundary was suggestive of
higher numbers and crowding of nuclei.
Figure 5.12: Left, Ultrahigh resolution OCT image of a polypoid adenoma of the colon. Highly
irregular glands and regions of high scattering intensity were observed. Inset, Magnified view of
the OCT image. Individual cells were not visible, but increased scattering at the basal boundary
was suggestive of higher numbers and crowding of nuclei. Right, Histology, Hematoxylin and
Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figures 13 and 14 show representative 3D OCT volume renderings of normal colon and a
polypoid adenoma of the colon, respectively. Rendered 3D OCT data can be viewed from a
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virtual surface perspective, yielding a view similar to that of magnification endoscopy. 3D OCT
data can also provide a subsurface view. In normal mucosa, crypts were sometimes difficult to
identify within individual cross-sectional OCT images. However using 3D OCT, crypts can be
visualized based on their shape and distribution in the en face plane. Folds in the epithelium
which can appear similar to crypts in an individual cross-sectional OCT image can be readily
identified and differentiated from crypts in 3D OCT. Comparison of the 3D OCT rendering of
normal colon versus polypoid adenoma shows striking differences in both the surface views as
well as the cutaway views. Normal colon exhibits a well organized distribution of crypts which
are uniform in size and spacing in the en face plane. In contrast, polypoid adenoma exhibits
irregular glandular structure. Sequential rendered en face views at different depths beneath the
surface of normal colon and polypoid adenoma can also be generated (Figures 15 and 16). Note
that crypts have increased light transmission artifacts at deeper depths. Videos showing
sequential en face slices through normal colon mucosa and polypoid adenoma are available in
the supplementary materials.
Figure 5.13: Volume rendering of normal colon mucosa: Left, Rendered cutaway view showing
individual crypts (C) and folds (F) in the en face plane. Right, En face view of the surface of the
colon mucosa. Folds in the mucosa could be clearly distinguished from crypts. Distinctive surface
pit patterns in normal mucosa could be seen. The rendered volume is approximately 1 mm x 1.2
mm x 1.3 mm in dimension and consists of 330 transverse slices. (Wavelength 1.09 pm,
Resolution 3.5 pm axial x 6 pm transverse)
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Figure 5.14: Volume rendering of a polypoid adenoma of the colon. Left, Rendered cutaway view
shows irregular glandular structures in adenoma (G, arrows) which were distinct from the uniform
crypt distribution in normal colon mucosa in Figure 5.13. Right, En face view of the surface of the
adenoma. Both the surface pattern and subsurface architecture were distinct from that of normal
colon mucosa. The rendered volume is approximately 1 mm x 1.2 mm x 1.3 mm in dimension and
consists of 275 transverse slices. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm
transverse)
Figure 5.15: 3D imaging enables sequential rendered enface views at different depths beneath the
surface of normal colon mucosa. Crypts can be visualized based on their shape and distribution in
the en face plane. Folds in the epithelium which can appear similar to crypts in an individual
cross-sectional OCT image can be readily identified and differentiated from crypts in 3D OCT.
The rendered image consists of 330 transverse slices. Movies showing sequential en face slices are
available in the supplemental materials. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm
transverse)
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Figure 5.16: Sequential rendered en face views at different depths beneath the surface of a
polypoid adenoma of the colon. Irregular glandular structures can be seen in adenoma which were
distinct from the uniform crypt distribution in normal colon mucosa. Both the surface pattern and
subsurface architecture were distinct from that of normal colon mucosa. The rendered image
consists of 275 transverse slices. Movies showing sequential en face slices are available in the
supplemental materials. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
DISCUSSION
Optical coherence tomography has been extensively investigated in endoscopic imaging. OCT
can image glandular organization of mucosal tissue and has demonstrated high sensitivities and
specificities for identifying pathologies such as Barrett's esophagus. Recent results have also
suggested the possibility of using OCT to differentiate hyperplastic versus adenomatous polyps,
which has implications for detecting dysplasia. However, the definitive identification of subtle
structural changes associated with dysplasia and other neoplastic changes remains challenging.
All clinical endoscopic imaging studies and virtually all ex vivo imaging studies to date have
been performed with standard resolution OCT using 10-15 pm axial image resolutions. For
these reasons, there has been considerable interest in improving the resolution and performance
of OCT imaging.
The application of ultrahigh resolution OCT in other fields such as ophthalmology has yielded
dramatic improvements in image quality and improved the ability to visualize internal retinal
structure. 127, 148,1 Ultrahigh resolution endoscopic OCT imaging with 3.7 Pim axial resolution
has recently been demonstrated in vivo in the rabbit esophagus and colon.154 This study
presented here is the highest resolution OCT imaging of human GI pathology that has been
performed to date. Performing imaging in the clinical pathology laboratory is more challenging
than imaging specimens transported to the research laboratory, but has the important advantage
of allowing access to specimens immediately after surgical excision, reducing tissue degradation
and significantly improving registration accuracy with histology. Imaging in the pathology
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laboratory is also an important step toward developing and validating new technology for future
endoscopic studies.
Ultrahigh resolution OCT improves image quality by improving axial imaging resolutions, image
sharpness, while also reducing speckle noise. OCT images, like ultrasound images, have speckle
which results in a grainy appearance, degrading image quality and making boundaries between
structures difficult to resolve.156 Imaging with a shorter coherence length, broader bandwidth
light source yields a finer grain speckle pattern and thereby improves image quality. Imaging
with improved transverse resolution also improves image quality by further reducing image
degradation due to speckle.
The first part of this ultrahigh resolution OCT imaging study used a Cr:Forsterite laser light
source at 1.3 pm wavelength with a 4.5 pm axial image resolution and -11 Pjm spot size.
Imaging was performed at the same wavelength as previous endoscopic and ex vivo studies but
with a 2-3x improvement in axial resolution and a 1.5-2x improvement in transverse resolution.
Ultrahigh resolution ex vivo OCT images had improved image quality compared to standard
resolution images in previous ex vivo studies. 9, 106-108, 117 Ultrahigh resolution images had
improved sharpness, reduced speckle and comparable imaging depths compared to standard
resolution images. The epithelial layer as well as the crypt structure and organization could be
imaged, but the overall improvement in image quality in this ex vivo imaging study was not as
dramatic as expected.
The second part of this ultrahigh resolution OCT imaging study used a Nd:Glass laser light
source at 1.1 pm wavelengths with a 3.5 pm axial image resolution and -6 pm spot size. This
study is of interest because compact and turnkey Nd:Glass laser light sources are commercially
available at this wavelength. Compact, high performance, fiber laser light sources at this
wavelength are also rapidly becoming available.157 It is therefore likely that future clinical
endoscopic imaging studies will be at this wavelength.
The second OCT system at 1.1 pm wavelength used a smaller 6 pm spot size which improved
the ability to visualize mucosal microstructure. Epithelial layers and glandular structure were
visualized better than at 1.3 pim wavelength using a 11 pm spot size. However, achieving 6 pm
spot sizes required high numerical aperture focusing which resulted in decreased the depth of
field. Visualization of the epithelial layer was possible only up to depths of 200-250 Pm,
sufficient for assessing the upper 2/3 of the mucosa. The limited depths of field may be
overcome in the future by using focus tracking methods. 8 6, 130, 158 The spot sizes used in this
study are achievable using standard micro-optics and could be incorporated into endoscopic OCT
systems. Further resolution improvement may be possible with microscopy techniques, which
will become available in the future for endoscopic applications.117159,160
In the studies at both 1.3 pm and 1.1 pm wavelengths, carcinoma and adenoma showed clear
loss of normal mucosal organization and increased backscattering in the epithelial layer, which
may be the result of nuclear crowding and enlarged nuclei. The presence of inflammatory
infiltrate may also contribute to increased scattering.
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The third part of the study demonstrated ultrahigh resolution 3D OCT imaging. This is the first
demonstration of ultrahigh resolution 3D OCT for GI pathology. 3D imaging and volume
rendering provided complementary information to cross-sectional OCT images, enabling
visualization of arbitrary planes and rendering of surface topography as well as subsurface tissue
microstructure. The ability to visualize en face planes at different depths enables glandular
organization to be assessed in a way not possible using individual OCT images.
Pervious studies of optical coherence microscopy (OCM) have demonstrated the value of en face
visualization." 7 Recent work using high-magnification chromoscopic colonoscopy has shown
that classification of the colorectal pit pattern in flat and depressed lesions has high sensitivity
and specificity for differentiating neoplastic from non-neoplastic lesions, and could potentially
be used for assessing suitability for endoscopic mucosal resection. 76'161-164 3D OCT can provide
additional information on subsurface architectural morphology which is not available with high-
magnification endoscopy and thus might be a valuable tool in future endoscopic studies.
Acquisition of 3D OCT data is possible in the ex vivo setting because motion artifacts are absent.
However, with recent advances in OCT imaging technology using spectral/Fourier domain
detection, dramatic improvements in imaging speed are possible. 165-167 Results in ophthalmic
imaging have achieved -100x improvements in imaging speeds.168-171 These high imaging
speeds make 3D OCT feasible in vivo. In addition to high speed imaging, novel scanning
devices such as micromechanical mirror or piezoelectric fiber scanners have also been recently
developed.172 -175 These advances promise to enable 3D OCT endoscopic imaging in the future.
CONCLUSION
In conclusion, this chapter demonstrated ultrahigh resolution OCT imaging of GI pathology in
the large and small intestine and correlation with histology. Performing the study in the
pathology laboratory setting enabled rapid access to tissue specimens, reducing degradation
effects and enabling accurate registration of OCT imaging with histology. Imaging at 1.3 Pim
wavelengths with a 4.5 pm axial image resolution and 11 pm spot size was first performed to
investigate the effect of improved axial resolution at standard OCT wavelengths. Studies were
also performed at 1.1 pm wavelengths with a 3.5 pm axial image resolution and 6 Pm spot size.
These studies are important because high performance lasers are commercially available at this
wavelength. Ultrahigh resolution imaging demonstrated clear delineation of the epithelium from
the lamina propria and visualization of individual crypts and glandular structure, but individual
cells were not visible. Decreasing the transverse spot size improved transverse image resolution,
but resulted in decreased depth of field. Image quality was improved compared to previous ex
vivo imaging studies, but was not as dramatic as expected. Recent studies of ultrahigh resolution
endoscopic OCT imaging in animals have shown excellent image quality in vivo.154 It is possible
that even with rapid access to specimens provided by this study, imaging in ex vivo specimens
may have lower contrast and sharpness than in vivo imaging. Further investigations using
ultrahigh resolution imaging in clinical endoscopic studies will be necessary to evaluate the
impact of improved resolution. Three-dimensional OCT imaging was demonstrated and enables
improved differentiation of en face and three-dimensional structure of glandular organization.
These studies can be used as a baseline for development of new OCT technology and could aid
the interpretation of future ultrahigh resolution endoscopic imaging studies.
72
Chapter 6
Ultrahigh Resolution and Three-Dimensional OCT Imaging
of Benign and Malignant Lesions in the Human Breast
INTRODUCTION
Breast cancer is a common and lethal disease. Approximately 215,990 new cases of invasive
breast cancer are expected to occur among women in the United States in 2004, accounting for
32% of all cancer cases in women. An estimated 40,110 deaths are expected from breast cancer
in 2004, making breast cancer the leading cause of cancer deaths in women after lung cancer. In
addition to invasive breast cancer, an estimated 59,390 new cases of in situ cancer are expected
to occur in women in 2004. 2 This translates to roughly a 1 in 8 chance for women of developing
invasive breast cancer in their lifetime.
Despite these high incidence rates, breast cancer mortality has declined by 2.5% per year in the
last decade due to both earlier detection and improved treatment methods. Early detection
increases treatment options and saves lives. The 5-year survival rate for local cancer is 97%.
However, this survival rate decreases dramatically to 79% if the cancer has spread regionally and
to 23% for distant metastasis. Survival is also stage-dependent, with early stage disease
correlated to best survival.2 Currently 63% of breast cancers are diagnosed at a localized stage,
which is attributed to effective use of mammography for screening as well as awareness of breast
cancer symptoms in the population.' 8
The fact that a significant percentage of early cancers are missed suggests that early detection
methods can still be improved. Sampling error is generally recognized as a major issue of fine-
needle aspiration cytology (FNAC), the standard method for obtaining breast samples for
diagnosis of palpable breast lesions.176' 177 Core-needle biopsy (CNBx) has come into more
widespread use for both palpable and non-palpable lesions due to the introduction of new more
sensitive spring-loaded biopsy "guns,"' 7 8 but still suffer from false-negative rates associated with
sampling error.179 With increased use of image guidance, higher sampling success rates have
been achieved,' 7 9 ' 180 but improvements are limited to lesions which are visible on ultrasound or
mammography, which have limited resolutions and therefore cannot adequately identify small
lesions or localize the full extent of lesions. In addition to the sampling limitations of diagnostic
techniques, surgical methods for cancer treatment critically depend on accurate methods for
assessment of microscopic resection margins. Women with negative excision margins have low
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rates of local recurrence following lumpectomy and radiation therapy, while positive resection
margins are associated with greater risk of recurrence. 18-83 However, methods such as
intraoperative frozen section analysis, which enables rapid histologic assessment of margins in
the operating suite, are time- and labor-intensive and may lead to inadequate assessment of large
specimens and loss of diagnostic material in small specimens.184 Newer methods such as
radioguided surgery 185, 186 have recently emerged as a method for resection guidance, with the
potential for more accurate and less unnecessary surgery. A technique capable of performing
subsurface, three-dimensional, micrometer-scale imaging in real time could permit guidance of
biopsy procedures to reduce sampling errors and intraoperative monitoring of biopsy and
surgical procedures, offering immediate information to the clinician and likely improving patient
outcome.
OPTICAL COHERENCE TOMOGRAPHY
OCT has a number of advantages which may make it a useful adjunct to current diagnostic
imaging modalities for breast cancer. OCT has higher resolution than any currently available
imaging technique used in breast cancer management. OCT can be incorporated into a wide
variety of endoscopic and laparoscopic imaging devices and can be used to guide open-field
surgical procedures.51' 52, 135, ,187, 1 Optical imaging needles have also been developed. An
OCT imaging needle could potentially be incorporated into core-biopsy devices to enable a less-
invasive "first-look" at a tissue specimen. Imaging could be performed over a greater overall
sampling volume than obtained by typical core-biopsy samples, reducing sampling error and
trauma associated with multiple invasive core-biopsy procedures. OCT imaging catheters could
also be used to assess the epithelial lining of the mammary duct system, in a manner similar to
mammary ductoscopy.'8 9 While ductoscopy provides only surface information, OCT could
provide real-time cross-sectional imaging of epithelial microstructure relevant for assessing
intraductal lesions.
To date, OCT has not been reported for imaging benign and malignant lesions of the human
breast. The role of OCT for research and image-guided surgery for breast cancer has recently
been shown ex vivo in the carcinogen-induced rat mammary tumor model. 190 In the reported
study, ultrahigh resolution OCT imaging of normal fibroadipose tissue, early-stage ductal cancer,
and infiltrative cancer in the rat mammary gland was presented. Three-dimensional rendering
demonstrated that tumor margins could be identified. Imaging results in the rat model suggested
that tumor cells exhibit increased scattering relative to the surrounding stroma.
This chapter investigates the feasibility of new ultrahigh resolution OCT technology for imaging
normal and neoplastic lesions of the human breast. In this study, normal, benign, and malignant
breast lesions were imaged ex vivo and correlated with histology. Imaging was performed using
a portable, ultrahigh resolution OCT system in the clinical pathology laboratory. Imaging in the
pathology laboratory allows rapid access to surgical specimens, reducing possible artifacts from
tissue degradation. Imaging in the pathology laboratory also provides access to diagnostically
critical specimens, such as lymph nodes, which are sensitive to removal from the hospital setting.
Ex vivo imaging also allows image registration to be carefully controlled to enable accurate
correlation of OCT images with histology.
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In this study, ultrahigh resolution OCT imaging was performed at ~1.1 Pim wavelength with a 3.5
pm axial resolution and 6 pm spot size using a Nd:Glass laser light source. The Nd:Glass laser
has the important advantage of being compact and commercially available and is therefore
suitable for future clinical imaging studies. This system performs imaging at wavelengths
shorter than the wavelength typically used in clinical OCT systems, but which enable higher
axial resolutions to be achieved. The transverse spot size was also chosen to be small in order to
improve transverse resolution over that used in standard resolution OCT systems. Three-
dimensional OCT imaging was also performed to investigate the utility of 3D visualization of
breast architectural morphology.
METHODS
Imaging studies were performed on freshly excised surgical specimens in the pathology
laboratory of the Beth Israel Deaconess Medical Center. These studies were approved by the
Institutional Review Board (IRB) at the Beth Israel Deaconess Medical Center and the
Committee for the Use of Humans as Experimental Subjects (COUHES) at the Massachusetts
Institute of Technology. Informed consent was not required since the study involved only
database review and ex vivo surgical specimens. Fresh specimens were selected based on the
presence of pathology upon gross examination, prompt arrival in the pathology laboratory, and
large specimen size, allowing normal and pathologic tissue to be collected from each specimen
for the study without interfering with routine diagnostic procedures. In selected cases,
specimens used for clinical diagnostic purposes were imaged immediately prior to placement in
cassettes for standard processing. All specimens available during the duration of the study which
met these criteria were imaged. For selected specimens with suspicion of in situ pathology,
additional mammography was performed on the excised specimens to guide OCT imaging to
areas of microcalcifications which have increased likelihood of pathology.
Ultrahigh Resolution OCT System and Imaging Parameters
The physical principles of OCT have been described previously.' " Ultrahigh resolution OCT
imaging was performed with 3.5 pm axial resolution in tissue using a femtosecond Nd:Glass
laser light source at a center wavelength of 1090 nm.96 This laser is commercially available
(High Q Laser Productions, Hohenems, Austria) and is compact, robust, and turn-key, making it
suitable for future in vivo clinical studies. Although shorter wavelengths are attenuated more
rapidly by tissue scattering, they enable finer axial resolutions for a given bandwidth as well as
smaller spot sizes. The transverse spot size was set to be -6 pm (FWHM) to examine the effects
of improved transverse resolution. This transverse spot size is a factor of 3-4x finer than
endoscopic OCT systems used in investigations of the gastrointestinal tract. The depth of field
was calculated to be ~140 pm. OCT imaging was performed using post objective scanning in
order to avoid aberrations and preserve the small spot size.
Three-dimensional OCT imaging was also performed. Three-dimensional data sets consisting of
200 to 350 individual OCT images spaced by 3 pm to 5 pm apart were generated by raster
scanning the beam. A 5 pm spacing was chosen for specimens with large architectural features
and a 3 pm spacing was used for all other specimens. Each OCT image in the raster scan
consisted of 600-1800 transverse pixels over 1-2 mm. This resulted in an axial scan spacing of
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0.6-3 pm by 3-5 pm. The 3D OCT data was processed and visualized using MRI software for
3D visualization and volume modeling (Amira, Mercury Computer Systems, Berlin).
Specimen Selection
Thirty-five cases from adult patients, consisting of a total of 142 separate specimens, were each
imaged within several hours of excision. Fresh specimens were selected based on the presence
of pathology upon radiographic findings or gross examination, prompt arrival in the pathology
laboratory, and large specimen size, allowing normal and pathologic tissue to be collected for the
study without interfering with routine diagnostic procedures. In selected cases, specimens used
for clinical diagnostic purposes were imaged immediately prior to placement in cassettes for
standard processing. For selected specimens with suspicion of in situ pathology, additional
mammography was performed on the excised specimens to guide OCT imaging to areas of
microcalcifications which have increased likelihood of pathology.
Collected specimens consisted of both normal and pathologic sites from each case. Benign
breast tissue imaged consisted of fibroadipose tissue including mammary ducts and lobules (n =
37), fibrocystic changes (n = 8), fibroadenoma (n = 7), ductal hyperplasia (n = 6), and isolated
cases of lipoma and neurofibroma. Malignant lesions imaged included ductal carcinoma-in-situ
(DCIS, n = 6), infiltrating ductal carcinoma (n = 12), infiltrating lobular carcinoma (n = 8), and
infiltrating carcinoma with ductal and lobular features (n = 5). Three infiltrating ductal
carcinoma specimens included regions of DCIS. Nine specimens of DCIS or cancer included
microcalcifications. Regions consisting of biopsy site changes (n = 23), fat necrosis (n = 3), and
fibrosis/scarring (n = 2) were also imaged. In addition to grossly normal and abnormal breast
lesions, lymph nodes specimens (n = 23, 5 positive, 18 negative) were imaged.
Imaging and Registration
Since the OCT light was in the near infrared and invisible to the eye, image registration was
performed with a visible green guiding beam which was coincident with the OCT imaging beam.
Imaging was performed without contact to the tissue. All images were scaled in the axial
direction by 1.38x to correct for the approximate index of refraction of tissue. 0 2  When
necessary, specimens were irrigated (RPMI 1640) to prevent dehydration during imaging.
Specimens were marked at the beginning and end of each OCT scan with microinjections of ink
to designate the imaging plane orientation. After imaging and inking, specimens were immersed
in Bouin's fixative for 2 seconds to fix the ink and prevent smearing. Specimens were then
placed in 10% buffered formalin, routinely processed and paraffin embedded. Multiple 5 Pim
thick tissue sections were obtained from the OCT imaging plane and stained with Hematoxylin
and Eosin. OCT images and corresponding histology sections were compared. Minor
discrepancies between histology and OCT images can be attributed to tissue fixation, processing
and sectioning artifacts.
RESULTS
OCT images and histology photomicrographs at 40x to 100x magnification are shown with
corresponding size scale bars. Histology is scaled with the same magnification as the OCT
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image. Ultrahigh resolution OCT imaging was performed at 1.1 Pim wavelengths with 3.5 Pim
axial resolution and -6 pm spot size. This represents an -1.5x coarser axial resolution and a -2x
finer transverse resolution than the previous ex vivo study performed in the rat model of induced
breast carcinogenesis.190 These studies use a Nd:Glass laser source which operates at a center
wavelength longer than the 800 nm wavelengths used in previous studies. However, imaging at
longer wavelengths permit increased penetration depth and lasers at this wavelength are more
readily available and suitable for future clinical use.
Normal
Imaging of normal breast tissue produced distinct images of fibrous stroma and adipose tissue
characteristic of normal breast. Figure 6.1 shows an ultrahigh resolution OCT image of normal
fibroadipose tissue and corresponding histology. Normal fibrous stroma appears heterogeneous
and highly scattering and can clearly be distinguished from surrounding adipose tissue.
Adipocytes appeared round or oval in shape, with individual well-circumscribed cell borders.
Adipose tissue exhibited decreased signal attenuation relative to the surrounding tissue at the
same depth. Consequently, regions directly beneath individual adipocytes appear to have higher
signal intensity than equivalent regions at the same depth.
At;,
Figure 6.1: OCT images of normal fibroadipose tissue. Fibrous stroma (F) appears heterogeneous
and highly scattering while individual adipocytes (A) appear low scattering, with individual well-
circumscribed scattering borders. Top, OCT; Bottom, Histology, Hematoxylin and Eosin 40x.
(Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
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A second OCT image with a magnified view of normal fibrous tissue is shown in Figure 6.2.
Fibrous stroma exhibits variations in scattering intensity which appear to correspond to local
variations in collagen fiber density.
Figure 6.2: OCT image of normal fibrous stroma. Insets show magnified regions of high
scattering corresponding to fibrous bundles. Left, OCT; Right, Histology, Hematoxylin and Eosin
40x and I00x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.3 and 6.4 shows ultrahigh resolution OCT images of a normal lobule of glands and a
terminal lobular duct unit, respectively. Normal glands were visible as round structures up to 100
pm in cross-section. Individual glands appeared less scattering than the surrounding fibrous
stroma and intervening intralobular stroma, and were clearly distinguishable from adipocytes.
Figure 6.3: OCT image of normal lobule of glands. Individual glands appeared low scattering
within higher scattering intralobular stroma. Left, OCT; Right, Histology, Hematoxylin and Eosin
40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
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Figure 6.4: OCT images of a terminal duct lobular unit. Magnified image of the lobule (right)
shows individual glands (G) as elliptical regions of lower scattering. A duct (D) is clearly visible
to the right of the lobule. Top, OCT; Bottom, Histology, Hematoxylin and Eosin 40x and 100x.
(Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
However, contrast between glandular structures and fibrous stroma was sometimes low, making
conclusive determination of the size, shape, and extent of individual glandular structures
difficult. Sequential images separated by 120 pm acquired in cross-section (Figure 6.5) enabled
the lobular duct unit to be identified in OCT images based on three-dimensional lobular
structure.
- 250 um
Figure 6.5: Sequence of cross-sectional OCT images of a terminal duct lobular unit. Volume
imaging enables three-dimensional tissue structure to be visualized. A duct network is clearly
visible in the last frame (arrow). Images are spaced by 120 pm between frames. (Wavelength 1.09
pm, Resolution 3.5 pm axial x 6 pm transverse)
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Ultrahigh resolution OCT images of a normal lactiferous duct are shown in Figure 6.6. The
ductal epithelium was visible as a lower scattering layer lining the duct, and was lower scattering
than the surrounding fibrous stroma. Duct lumens were visible in ducts larger than -50 pm in
diameter, and the basal boundary between the myoepithelial layer and stroma could be
distinguished. Ducts of different diameters appeared similar in architecture and could be
distinguished by their continuous and branching structure. Ducts with diameters as small as 20-
25 pm could be identified based on three-dimensional architecture in sequential transverse OCT
images. Smaller ducts appeared similar in cross-section to glands, but could be distinguished
based on their continuous structure.
Figure 6.6: OCT images of normal lactiferous duct. Magnified image of the duct (right) shows
normal ductal epithelium (Ep) appearing lower scattering than the surrounding fibrous stroma. The
basal boundary (B) between the myoepithelium and stroma is visible. Top, OCT; Bottom,
Histology, Hematoxylin and Eosin 40x and 100x. (Wavelength 1.09 pm, Resolution 3.5 pm axial
x 6 pm transverse)
Figure 6.7 shows an image of normal lymph node imaged through the lymph node capsule with
representative histology. OCT was able to identify and image through the extent of the
fatty/fibrous capsule, but the body of the node appeared relatively uniformly scattering with no
obvious follicular structure. Figure 6.8 shows an image of the node body acquired after the node
was bisected for routine histopathology. Imaging through the bisected node identified regions of
increased scattering which may correspond to boundaries between germinal centers. Highly
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scattering continuous structures within the lymph node were visible which may correspond to
lymphatic vessels or the trabecular sinuses. Fatty replacement of normal lymphatic tissue was
also visible in OCT images.
Figure 6.7: OCT image of normal lymph node imaged through capsule. Fibrous tissue of the
capsule is visible as a highly scattering band. Left, OCT; Right, Histology, Hematoxylin and Eosin
40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.8: OCT image of bisected normal lymph node. Highly scattering continuous structures
within the lymph node may correspond to lymphatic vessels or trabecula. Left, OCT; Right,
Histology, Hematoxylin and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm
transverse)
Figures 6.9 and 6.10 show images of normal lymph node and normal fibrous tissue before and
after averaging. Averaging reduces noise due to speckle and improves image quality. Imaging
was performed in the same location for ~100 frames. Averaging images of both lymph node and
fibrous tissue clearly reduces speckle, but significantly enhanced contrast between internal tissue
structures was not observed.
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Figure 6.9: OCT image of bisected normal lymph node before and after averaging. A: Single
image. B: Average of 99 images at the same location. A, B: OCT; C: Histology, Hematoxylin and
Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
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Figure 6.10: OCT image of normal fibroadipose tissue before and after averaging. Left: Single
image. Right: Average of 101 images at the same location. (Wavelength 1.09 pm, Resolution 3.5
pm axial x 6 pm transverse)
Benign
Figure 6.11 shows a representative OCT image of fibrocystic changes. Individual cysts within
fibrous tissue appeared well-circumscribed and contained scattering material. Epithelium lining
cysts was visible as a thin, ~30-40 pm band lining cysts. In contrast, epithelium exhibiting
apocrine metaplasia appeared thickened and irregular (Figure 6.12).
82
II
I II
Figure 6.11: OCT image of fibrocystic changes. Individual cysts within fibrous stroma appeared
well-circumscribed and irregularly filled with scattering material. Epithelium is occasionally
visible as a uniform scattering band lining cysts. Left, OCT; Right, Histology, Hematoxylin and
Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.12: OCT images of apocrine metaplasia within cysts. Metaplastic epithelium is visible in
the magnified image (bottom) as a thickened irregular band lining cysts (arrows). Left, OCT;
Right, Histology, Hematoxylin and Eosin 40x and I00x. (Wavelength 1.09 pm, Resolution 3.5 pm
axial x 6 pm transverse)
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Figure 6.13 shows OCT image of a benign cyst within breast tissue exhibiting fibrocystic
changes. Rare calcium oxalate calcification occasionally present within cysts were visible as
focal regions of increased scattering with pronounced shadowing in the OCT images.
Figure 6.13: OCT image of a large cyst. Insets show calcium oxalate calcifications visible as focal
regions of high scattering with pronounced shadowing. Left, OCT; Right, Histology, Hematoxylin
and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.14 shows a representative OCT image of fibroadenoma. Fibroadenoma specimens
imaged appeared more uniformly scattering than the heterogeneous fibrous stroma associated
with normal fibroadipose tissue. Regions of high scattering suggestive of boundaries between
stromal nodules were observed. Compressed ducts with epithelium were visible as finger-like
projections of low scattering.
Figure 6.14: OCT image of benign fibroadenoma. Stromal nodules appeared more uniformly
scattering than normal fibrous tissue and compressed ducts with epithelial component (arrows)
were visible as finger-like regions of low scattering. Left, OCT; Right, Histology, Hematoxylin
and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
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OCT images of benign ductal hyperplasia are shown in Figure 6.15. Highly-scattering finger-like
projections into the duct lumen were visible which were distinct from the appearance of normal
ducts (Figure 6.6). These projections may correspond to fibrovascular cores projecting into the
lumen or boundaries between folds of hyperplastic epithelium within the duct lumen. Sequential
images acquired in cross-section allow the architecture of hyperplastic epithelium to be
visualized (Figure 6.16).
Figure 6.15: OCT images of ductal hyperplasia. Magnification of the duct region (right) shows
highly scattering projections into the duct lumen corresponding to hyperplastic epithelium or
fibrovascular cores (arrows). Top, OCT; Bottom, Histology, Hematoxylin and Eosin 40x and
100x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
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Figure 6.16: Sequence of cross-sectional OCT images of ductal hyperplasia showing three-
dimensional structure of the duct lumen. Consecutive frames are spaced by 40 pm between
frames. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.17 shows OCT images of biopsy site fat necrosis. Irregular adipose tissue and focal
regions of increased scattering was observed in areas of fat necrosis, and image penetration depth
was noticeably reduced.
~,
Figure 6.17: OCT image of biopsy site fat necrosis. Irregular low scattering necrotic adipose cells
are clearly visible in the OCT images. Left, OCT; Right, Histology, Hematoxylin and Eosin 40x.
(Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Fibrosis and scarring present in specimens was visible in OCT images as regions of sharply
increased scattering (Figure 6.18). Distorted ductal architecture surrounded by diffusely
scattering stroma was also visible in some OCT images and corresponding to elastotic changes
surrounding ducts (Figure 6.18). Anthracotic pigment was also visible in lymph nodes as focal
regions of increased scattering with pronounced shadowing (Figure 6.19).
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Figure 6.18: OCT images of fibrosis (left) and elastotic changes surrounding a duct (right). Top,
OCT; Bottom, Histology, Hematoxylin and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm
axial x 6 pm transverse)
Figure 6.19: OCT image of anthracotic pigment occurring within a lymph node (inset and
arrows). Left, OCT image; Center, Histology of inset region, Hematoxylin and Eosin 200x; Right,
Photograph of bisected normal lymph node indicating imaging plane. (Wavelength 1.09 pm,
Resolution 3.5 pm axial x 6 pm transverse)
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Malignant
OCT images of DCIS within lobules and ducts are shown in Figure 6.20 and Figure 6.21,
respectively. In Figure 6.20, tumor cells within the lobules appear lower scattering than the
surrounding fibrous stroma. Dilation of the lobules due to the tumor cells and architectural
distortion of the surrounding stroma was clearly visible. A microcalcification which was not
sectioned in the corresponding histology micrograph was visible in the OCT image as a focal
region of increased scattering with pronounced shadowing.
Figure 6.20: OCT images of DCIS occurring within lobules. Tumor cells appeared uniformly
low-scattering and dilation and architectural distortion of the lobules is visible. A
microcalcification (C, circled at right) within the lobules appears highly scattering with
pronounced shadowing. Top, OCT; Bottom, Histology, Hematoxylin and Eosin 40x. (Wavelength
1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.21 shows OCT images of DCIS in ducts. Tumor cells within a large duct also appeared
uniformly lower scattering relative to the surrounding thick collagenous stroma, and dilation of
the duct is also visible.
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Figure 6.21: OCT images of DCIS within a duct. The duct lumen is completely occluded with
low scattering tumor cells. Diffusely infilitrating tumor cells are present in the surrounding highly
scattering desmoplastic stroma. Top, OCT; Bottom, Histology, Hematoxylin and Eosin 40x and
100x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.22 shows OCT images of infiltrative ductal carcinoma. OCT images of ductal
carcinoma revealed highly scattering and irregular regions which appeared to correspond to
invasive cancer. Tongues of cancer cells exhibited increased scattering compared to surrounding
regions and extended irregularly into the stroma.
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Figure 6.22: OCT images of infiltrative ductal carcinoma. Highly scattering regions (arrows) are
visible in the OCT images which correspond to tongues of invasive cancer. A, B: OCT; C:
Histology, Hematoxylin and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm
transverse)
OCT images of a microcalcification and corresponding histology of within a region of invasive
ductal carcinoma are shown in Figure 6.23. Microcalcifications were visible as focal highly
scattering regions which exhibited dramatic shadowing relative to regions of invasive cancer
Figure 6.23: OCT images of microcalcification within a region of infiltrating ductal carcinoma.
Microcalcification (M) appears as regions of high scattering which strongly shadows deeper
regions. Invasive cancer (C) is visible in the vicinity of the calcification. A, B: OCT; C: Histology,
Hematoxylin and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
Figure 6.24 shows and OCT image of infiltrative lobular carcinoma. In contrast to infiltrating
ductal carcinoma, OCT images of lobular carcinoma appeared more homogeneously scattering.
Isolated regions of increased scattering appeared to correspond to intervening fibrotic stroma,
and entrapped fat was visible in some specimens. Specimens of infiltrating lobular carcinoma
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were often indistinguishable on OCT from regions of fibrosis, fat necrosis, and inflammatory
infiltrate associated with biopsy site changes.
Figure 6.24: OCT image of infiltrating lobular carcinoma. Regions with densely infiltrating tumor
cells appear low scattering and homogeneous, with isolated regions of entrapped fat. Left, OCT;
Right, Histology, Hematoxylin and Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6
pm transverse)
Figure 6.25 shows OCT images of lobular carcinoma metastasis to lymph node. Lymph nodes
containing metastatic lobular carcinoma were unremarkable and were not distinguishable from
normal lymph nodes based on OCT images. No specimens of lymph nodes with metastatic ductal
carcinoma were available to image in this study.
Figure 6.25: OCT image of metastatic infiltrating lobular carcinoma in a lymph node. Metastatic
lobular carcinoma appears uniformly scattering. Left: OCT; Right: Histology, Hematoxylin and
Eosin 40x. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm transverse)
91
Three-dimensional rendering
3D imaging and volume rendering provided complementary information to cross-sectional OCT
images, enabling visualization of arbitrary planes as well as subsurface tissue microstructure.
Figures 6.26 shows a sequence of rendered en face images of fibroadipose tissue, similar to the
view provided by microscopy. En face rendered images have the advantage that all image points
are in constant focus. Note that regions beneath adipocytes exhibit increased scattering at deeper
depths because of decreased light attenuation through adipocytes.
Figure 6.26: Sequence of en face OCT images of normal fibroadipose tissue spaced every 75 pm
from the tissue surface. En face imaging enables the image plane to be kept in constant focus.
Each image is 1 mm x 1 mm in dimension and consists of approximately 850 x 333 pixels
rendered from 333 transverse slices. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm
transverse)
Figure 6.27 show a comparison of en face images of normal fibroadipose tissue and
fibroadenoma. The ability to visualize arbitrary planes at different depths enables the three-
dimensional tissue organization to be assessed in a way not possible using individual OCT
images. Boundaries between stromal nodules (arrows) are clearly visible in the fibroadenoma
which was distinct from the more heterogeneous fibrous stroma in the image of normal tissue.
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Figure 6.27: Rendered en face OCT images of normal fibroadipose tissue (top) and fibroadenoma
(bottom). Distinctive bands indicating lobular stromal hyperplasia is visible in the fibroadenoma
which is absent in normal fibrous tissue. (Wavelength 1.09 pm, Resolution 3.5 pm axial x 6 pm
transverse)
Three-dimensional imaging also enables identification of low-contrast structures by tracking
image features in multiple cross-sectional planes. Figure 6.28 shows normal fibroadipose tissue
in contrast with DCIS within lobules and infiltrative lobular carcinoma. Large dilated lobules
within regions of fat are visible in the image of DCIS which correspond to those seen in
histology. Infiltrating lobular carcinoma with intervening fibrotic tissue more closely resembles
structures visible in the corresponding histology in the en face plane than in the transverse plane
(Figure 6.24).
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Figure 6.28: Rendered en face OCT images at 100 pm below the tissue surface. A, Normal breast
stroma with adipocytes and fibrous tissue; B, DCIS in dilated lobules within fat; C, infiltrating
lobular carcinoma. Histology (D-F) is obtained from corresponding specimens in the plane
perpendicular to the OCT images. Each image is 1 mm x 1 mm in dimension and consists of
approximately 850 x 333 pixels rendered from 333 transverse slices. (Wavelength 1.09 pm,
Resolution 3.5 pm axial x 6 pm transverse)
Representative videos showing three-dimensional structure of a terminal lobular duct unit,
normal lactiferous ducts, cystic changes, fibroadenoma, DCIS, infiltrative cancer, and
microcalcifications are available in the supplemental materials.
DISCUSSION
Optical coherence tomography has been extensively investigated in vivo in ophthalmology,
cardiology, and gastroenterology, but few published reports have examined OCT for imaging
solid organs such as the breast. In part, practical considerations make in vivo imaging of solid
organs complex. OCT imaging is limited in scattering tissues to penetration depths on the order
of 2-3 mm, therefore imaging must be performed through an invasive imaging device. Scanning
and image generation is also challenging from an engineering perspective because of the desire
to make invasive imaging probes as small as possible. However, the high incidence and mortality
associated with cancers of solid organs such as the breast and prostate make research into
imaging techniques for early detection and treatment worth investigation.
Sampling error is generally recognized as a major issue of fine-needle aspiration cytology
(FNAC), the standard method for obtaining breast samples for diagnosis of palpable breast
lesions. 176,177 Core-needle biopsy (CNBx) has come into more widespread use for both palpable
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and non-palpable lesions due to the introduction of new more sensitive spring-loaded biopsy
"guns, 57 but still suffer from false-negative rates associated with sampling error.'7 1 With
increased use of image guidance, higher sampling success rates have been achieved, 179' 180 but
improvements are limited to lesions which are visible on ultrasound or mammography, which
have limited resolutions and therefore cannot adequately identify small lesions or localize the
full extent of lesions. In addition to the sampling limitations of diagnostic techniques, surgical
methods for cancer treatment critically depend on accurate methods for assessment of
microscopic resection margins. Negative excision margins are associated with low rates of local
recurrence following lumpectomy and radiation therapy, while positive resection margins are
associated with greater risk of recurrence.1 8 1-183 Methods such as intraoperative frozen section
analysis, which enables rapid histologic assessment of margins in the operating suite, are time-
and labor-intensive and may lead to inadequate assessment of large specimens and loss of
diagnostic material in small specimens.184 Newer methods such as radioguided surgery
1 85
' 186
have recently emerged as a method for resection guidance, with the potential for more accurate
and less unnecessary surgery. A technique capable of performing subsurface, three-dimensional,
micrometer-scale imaging in real time could permit guidance of biopsy procedures to reduce
sampling errors and intraoperative monitoring of biopsy and surgical procedures, offering
immediate information to the clinician and likely improving patient outcome.
The role of OCT in breast cancer research has recently been investigated ex vivo in the
carcinogen-induced rat mammary tumor model.190 In the reported study, ultrahigh resolution
OCT imaging of normal fibroadipose tissue, early-stage ductal cancer, and infiltrative cancer in
the rat mammary gland was presented. Three-dimensional rendering suggested tumor margins
could be identified. Imaging results in the rat model suggested that tumor cells exhibit increased
scattering relative to the surrounding stroma.
In this study, OCT was shown to enable imaging of benign and malignant lesions in the human
breast. Normal mammary ducts and lobules could be identified within fibroadipose tissue. The
epithelium and lumens of normal ducts larger than -50 pm in diameter were visualized, while
smaller ducts 20-25 pm in size could be distinguished based on their continuous and branching
architecture in sequential transverse images. In contrast, lumens of ducts with ductal hyperplasia
as well as ductal carcinoma-in-situ were not visible. These ducts were also associated with
irregular scattering projections into the duct lumen which may correspond to presence of
fibrovascular cores or collagenous stroma. Lobules with DCIS also were associated with
pronounced architectural distortion of the surrounding stroma due to dilation of the lobules with
cancer cells. Occlusion of lumens in combination with surrounding architectural distortion in the
background of otherwise normal-appearing fibroadipose tissue could potentially therefore be
used as a characteristic for hyperplasia or DCIS. Presence of microcalcifications within ducts and
lobules, which were also visible in OCT images, could also additionally be used as an indirect
sign of possible malignancy. In addition, infiltrative ductal carcinoma also appeared as regions of
increased scattering relative to adjacent stroma. This increased scattering may result from
relatively increased nuclear-to-cytoplasmic ratios of atypical cells compared to normal cells. This
is consistent with earlier reports which describe breast cancer cells as exhibiting increased
scattering relative to the surrounding stroma.'90 However, the low scattering associated with
tumor cells in specimens with DCIS and infiltrative lobular carcinoma in this study suggests that
the increased scattering associated with infiltrating ductal carcinoma is more likely associated
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with desmoplastic reaction to infiltrating cancer than malignant cellular change. Presence of
biopsy site changes, elastotic stroma, and scarring also complicate image interpretation. Given
the wide range of changes associated with malignant breast lesions, imaging of larger numbers of
specimens would be required to determine if these increased scattering changes can be
consistently associated with neoplastic development.
This study also demonstrated ultrahigh resolution 3D OCT imaging of both benign and
malignant human breast lesions. 3D imaging and rendering provided complementary information
to cross-sectional OCT images, enabling visualization of arbitrary planes and tracking of features
through multiple image planes, enabling identification of structures difficult to visualize from
single images. The ability to render a tissue volume enables three-dimensional tissue
organization to be assessed. A 3D reconstructed specimen can be rotated and arbitrary planes
can be viewed from any angle, which is impossible with conventional light microscopy. OCT
visualization in the en face plane also has the advantage that the entire plane of the image is
within constant focus, allowing higher numerical aperture focusing and higher transverse
resolutions to be achieved.
Acquisition of 3D OCT data is possible in the ex vivo setting of this study because motion
artifacts are absent. However, with recent advances in OCT imaging technology using
spectral/Fourier domain detection, dramatic improvements in imaging speed are possible.165-167
Recent results in ophthalmic imaging have achieved ~100x improvements in imaging speeds.168-
171 These extremely high imaging speeds make 3D OCT feasible in an in vivo setting. In
addition to high speed imaging, novel scanning devices such as micromechanical mirror or
piezoelectric fiber scanners have also been recently developed. 172-175 These advances promise to
enable 3D OCT laparoscopic imaging in the future.
CONCLUSION
This study presents the first ultrahigh resolution OCT images of normal and neoplastic lesions of
the human breast. OCT imaging of normal, benign, and malignant breast lesions was performed
and correlated with histology. Ultrahigh resolution imaging of normal mammary ducts and
lobules was demonstrated, and ductal hyperplasia, microcalcifications, and infiltrative carcinoma
could be visualized. Three-dimensional OCT imaging enables differentiation of en face and
three-dimensional structure of tissue organization. It is possible that even with rapid access to
specimens provided by this study, imaging in ex vivo specimens may have lower contrast and
sharpness than in vivo imaging. Further investigations using larger numbers of specimens and
blinded studies will be required in order to establish sensitivities and specificities to determine
the usefulness of OCT for identifying early stage breast cancers and suitability for pursuing in
vivo studies. These studies can be used as a baseline for development of new imaging technology
for research in breast cancer and could aid the interpretation of future in vivo intraoperative OCT
imaging studies.
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Chapter 7
Summary and Conclusions
SUMMARY
Optical coherence tomography (OCT) is an emerging biomedical imaging technology that
enables real-time, high-resolution imaging of tissue microstructure. OCT generates cross-
sectional images of tissue optical backscattering as a function of depth with a higher resolution
than any clinically available imaging technique. OCT can also be incorporated into a variety of
fiber-optic devices, enabling development of minimally-invasive imaging probes for clinical
applications.
Recent advances in broadband mirror and nonlinear fiber technology have allowed the
development of portable broadband laser sources which enable a 3-10x improvement in OCT
axial imaging resolution. This thesis describes the development of one such novel source for
high-speed ultrahigh resolution OCT imaging and the application of portable ultrahigh resolution
OCT technology for imaging human early neoplastic pathologies in the pathology laboratory
setting. Early features of cancer are often focal, with diagnosis which may differ from slide to
slide. Precise registration with histology is therefore required for correlation of OCT imaging
with histology and accurate image interpretation. Imaging in the ex vivo setting enables careful
control of imaging parameters, allowing correlation of OCT images with histology which is
difficult to perform in vivo. Ex vivo studies allow systematic investigation of imaging parameters
and optical markers characteristic of disease pathology to be investigated, establishing a baseline
for future in vivo imaging studies. Studies in the pathology laboratory also enable rapid access to
fresh surgical specimens, including diagnostically sensitive tissues and tumor margins, which are
difficult to obtain in the laboratory setting.
It is possible that even with rapid access to specimens, imaging ex vivo specimens may result in
lower contrast and sharpness than in vivo imaging. In Chapter 2, studies of the effect of tissue
preservation on contrast in OCT images were performed in order to establish optimal tissue
handling protocol for ex vivo imaging. Imaging was performed in vivo and ex vivo on the same
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tissue site, and preservation using isotonic phosphate-buffered saline and DMEM cell culture
media was investigated. Optical backscattering is sensitive to variations in refractive index in the
tissue sample, and it was possible that local charges in tissue density as a result of tissue
compression or stretching would change optical contrast. Therefore specimens approximately 1
cm x 1 cm in size were used in this study to minimize the effect of changes in optical contrast
induced by loss of local supporting tissue structure. Minimal changes in the hamster cheek pouch
were observed in the first 2 hours after excision using DMEM solution.
Imaging of normal, benign, and malignant lesions from fresh surgical specimens of thyroid,
small and large intestine, and breast were performed in order to assess the feasibility of using
ultrahigh resolution OCT for imaging early stage pathologies in these organ systems.
Current diagnostic imaging modalities of the thyroid gland cannot reliably distinguish benign
from malignant lesions, primarily because of their inability to visualize microscopic structure.
The feasibility of OCT for imaging thyroid tissue was explored for the first time ex vivo on the
human thyroid gland. OCT imaging was performed at 1.3 pm wavelengths with a 4.5 pm axial
image resolution and 11 pm spot size. Additional preliminary studies were also performed at 1.1
pm wavelengths with a 3.5 pm axial image resolution and 6 pm spot size. Imaging was
performed in real time at 2-4 frames on three post-mortem and 20 surgically excised thyroid
glands containing normal, hyperplastic and neoplastic tissue. Imaging of the thyroid gland
clearly visualized individual colloid-filled follicles and their supporting stroma in normal
thyroid, as well as the follicular epithelial layer in many specimens. Contrast between the colloid
and follicular epithelium was high and signal attenuation was low, leading to increased image
penetration depths of up to 2-3 millimeters. Images of degenerative, hyperplastic, adenomatous
and malignant change within the thyroid gland were shown to correlate well with corresponding
histopathologic findings. The ability of optical coherence tomography to image thyroid tissue
microarchitecture makes it a potentially powerful technology that can be used to assess the
thyroid gland at a resolution greater than currently available clinical imaging modalities.
Ultrahigh resolution and three-dimensional OCT was also investigated for ex vivo imaging of the
large and small intestine. Extensive in vivo imaging studies in the GI tract have been performed
in both animal models and in humans. Large patient studies have shown that OCT has high
sensitivities and specificities for identifying Barrett's esophagus. However, currently all clinical
studies have been performed using standard resolution OCT with 10-15 Pim axial resolution.
Ultrahigh resolution OCT could enhance imaging performance for the identification of early
neoplastic changes. In this study, OCT imaging was performed on fresh surgical specimens from
the large and small intestine in the pathology laboratory. Imaging at 1.3 Pim wavelengths with a
4.5 pim axial image resolution and 11 pm spot size was first performed to investigate the effect
of improved axial resolution at standard OCT wavelengths. Studies were also performed at 1.1
pm wavelengths with a 3.5 pm axial image resolution and 6 Pim spot size. These studies are
important because high performance lasers are commercially available at this wavelength.
Normal and pathologic areas from 23 surgical specimens of the large and small intestine were
imaged. Ultrahigh resolution OCT distinguished the epithelial layer of the mucosa and visualized
individual villi, glands, and crypts. Finer transverse resolutions improved visualization of
features such as the epithelium, but reduced depth of field. Architectural distortion of glands
from inflammatory and neoplastic processes was observed. Three-dimensional rendering
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enabled visualization of surface pit pattern and mucosal folds as well as subsurface crypt
microstructure. The potential of OCT to both render surface morphology and visualize
subsurface tissue microstructure has the potential to aid in real-time staging of lesions for
endoscopic mucosal resection. These studies can be used as a baseline for development of new
OCT technology and could aid the interpretation of future ultrahigh resolution endoscopic
imaging studies.
This thesis also investigated the feasibility of OCT for imaging benign and malignant lesions of
the human breast. This study presents the first ultrahigh resolution OCT images of human breast
to our knowledge. Studies were performed at 1.1 prm wavelengths with a 3.5 pm axial image
resolution and 6 pm spot size. Thirteen cases from adult patients, consisting of a total of 41
separate specimens, were each imaged within several hours of excision. Collected specimens
consisted of both normal and pathologic sites from each case. Selected specimens with suspicion
of in situ carcinoma were also mammogrammed separately to guide OCT imaging to regions of
identified microcalcifications suspicious for carcinoma. OCT was demonstrated to enable
visualization of normal mammary ducts and lobules as well as normal fibroadipose tissue. The
epithelial layer lining normal ducts was identified. Specimens of atypical ductal hyperplasia,
fibroadenoma, lipoma, microcalcifications, and infiltrating ductal carcinoma exhibited
characteristic features and correlated well with histology. Three-dimensional imaging and
rendering was also performed. Optical imaging contrast between normal glandular structure and
fibrous stroma in breast tissue was relatively low. Tracking suspected glandular structures
through multiple imaging planes was important for identifying characteristic features
differentiating glands from the adjacent stroma and differentiating glands from small ducts in
cross-section. Further investigations using larger numbers of specimens and blinded studies will
be required in order to establish sensitivities and specificities to determine the usefulness of OCT
for identifying early stage breast cancers. These studies can be used as a baseline for
development of new imaging technology for research in breast cancer and could serve as an
adjunct to investigative studies of mammary ductoscopy or aid the interpretation of in vivo
intraoperative OCT imaging studies.
FUTURE STUDIES
Hamster model of squamous carcinoma
The ability of ultrahigh resolution OCT to identify features associated with early stage dysplastic
changes can also be investigated in animal models of tumor carcinogenesis. Tumor induction in
animal models is well-characterized, and provides controlled timepoints for imaging at different
stages of development. Imaging in vivo in animal models is well-controlled and histology can be
obtained at different timepoints, enabling OCT images to be directly correlated with developing
pathology to establish optical markers for neoplastic progression.
The Syrian golden hamster cheek pouch carcinogenesis model closely resemble the events
involved in the development of premalignant and malignant human oral cancers.19 1-193 In
addition, it is one of the most well-characterized models for squamous cell carcinomas, which
affects a wide variety of organs including the skin, oral cavity, pharynx, larynx, and cervix.
Using 7,12-dimethylbenzaanthracene (DMBA)-induced carcinogenesis, early dysplastic changes
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through invasive squamous cell carcinoma can be induced during a 12 week timecourse.194
Because it has a well-controlled cancer progression, the hamster cheek pouch model has been
used in other studies involving fluorescence and optical imaging of neoplastic changes.1
21
, 123, 195-
198 The feasibility of using OCT for imaging hamster cheek pouch tumorigenesis has recently
been reported.199 However, this study used lower resolutions and did not demonstrate imaging of
early dysplastic changes which arise in the epithelium.
In this thesis, ultrahigh resolution OCT was shown to enable clear visualization of normal
keratinized squamous epithelium in the hamster cheek pouch, as well as the underlying muscle
and supporting tissue layers and vessels. Normal hamster cheek pouch epithelium appeared
homogeneous and uniformly scattering and could be clearly delineated from the underlying
lamina propria. Clear visualization and characterization of normal squamous epithelium has been
demonstrated, therefore this model would be ideally suited for investigating the ability of OCT to
identify optical scattering changes associated with dysplasia occurring within the squamous
epithelial layer. It is possible that early dysplastic changes may be beyond the imaging resolution
and contrast of even ultrahigh resolution OCT, therefore microscopy methods should be
investigated in parallel.15 9, 200 The hamster cheek pouch model allows repeatable imaging of the
tissue architecture, and therefore serves as an excellent model for assessing the ability of
ultrahigh resolution OCT for imaging early neoplastic changes in squamous epithelial tissues and
assessing neoplastic progression.
AOM murine model
The use of azoxymethane (AOM) carcinogen is an established model for colorectal cancer that
has been demonstrated to induce tumors within the murine colon. AOM is metabolite of 1,2-
Dimethyihydrazine (DMH) which has been used extensively to induce colon tumors in a number
of rodent species.201-207 AOM tumors share similar histological characteristics with human
tumors,2 08 ,209 and thus serves as a good model to study tumor progression within the colon. The
use of colon-specific carcinogens in murine models has been shown to induce early stage
morphological changes (aberrant crypts) through dysplasia to invasive adenocarcinoma. 201-203, 206
In the rat AOM model, neoplastic progression from ACF begin as early as 5 weeks, progress
through multiple crypts through gross adenoma, with invasive adenocarcinoma by 53 weeks.203
206, 210 Flat dysplastic lesions occurring in the AOM models may also serve as a useful model for
detection of non-pedunculated dysplasia-associated lesions, which can occur in human patients
with chronic inflammatory bowel disease. These lesions are often difficult to distinguish and
associated with a significantly increased risk of colorectal cancer.147,211
By studying colonic epithelium during tumor induction in the AOM model, the architectural and
morphological changes associated with gastrointestinal tumor progression can be investigated.
These studies would allow investigation of OCT imaging markers for dysplasia in model of
adenocarcinoma, the most common form of carcinoma in the prostate as well as the colorectal
tract. Previous studies have demonstrated the capability of fiberoptic confocal imaging to
visualize architecture within the rat colon.2 12 , 213 In vivo imaging of colonic tumors in mice has
also been investigated with standard resolution OCT imaging.21 4 Ultrahigh resolution imaging
techniques can first be performed ex vivo in order to investigate imaging of early stage colonic
tumors based on architectural changes. As it is possible that early dysplastic changes may be
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beyond the imaging resolution and contrast of even ultrahigh resolution OCT, microscopy
techniques can also be investigated in this model in parallel to assess cellular-level features. 159'
200 Identification of morphological changes in the early stages of neoplastic development and
progression would lead to valuable insight into this and other colonic cancer models.
In vivo studies in the upper gastrointestinal tract
A particularly promising application of optical biopsy using OCT is as an adjunct to endoscopic
imaging of the gastrointestinal tract. Numerous in vivo endoscopic OCT studies have been
performed indicating that OCT has the potential to distinguish morphological changes associated
with gastrointestinal pathologies. However, all clinical studies to date have used standard
resolution OCT with 10-15 pm axial resolution and have been unable to identify early neoplastic
changes associated with high-grade dysplasia. If ultrahigh resolution OCT can be demonstrated
to significantly enhance imaging performance for the identification of dysplastic changes, OCT
could become a powerful tool for guiding excisional biopsy to improve sensitivity and reduce
false negative rates in patients at risk for developing esophageal cancer.
These ongoing studies use a prototype compact Cr4*Forsterite laser source, identical to one of
the two sources used in Chapters 4 and 5 of this thesis. Figure 7.1 A shows a representative in
vivo ultrahigh resolution OCT image of normal esophagus in a human subject. The OCT image
shows the relatively homogeneous squamous epithelium (ep), the higher-backscattering lamina
propria (lp), the lower-backscattering muscularis mucosa (mm), the higher-backscattering
submucosa (sm), and the low-backscattering and thick muscularis propria (mp). In contrast,
Figure 7. 1B shows a representative OCT image of a region of Barrett's esophagus from the same
patient. The OCT images demonstrate clear differences between Barrett's esophagus when
compared to normal squamous epithelium. The uniformly layered structure of normal esophagus
has been disrupted by the presence of multiple gland-like structures. Boundaries between
individual glands appear highly scattering, with a lower-scattering epithelial layer lining the
glands.
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Figure 7.1: A. Image of normal esophagus in vivo. The normal layered structure of the esophagus
is well defined with a clearly visible homogeneous squamous epithelium (ep) above the highly
backscattering lamina propria (lp). Deeper layers of the muscularis mucosa (mm), submucosa
(sm), and muscularis propria (mp) are also visible. B. Image of Barrett's esophagus from the same
patient shows characteristic disruption of the epithelium, with multiple gland-like structures.
(Wavelength 1.26 pm, Resolution 3.7 pm axial x 15 pm transverse)
The sensitivity and specificity of standard resolution OCT for detecting Barrett's esophagus has
recently been demonstrated.72 Improving axial resolution and reducing speckle using ultrahigh
resolution OCT imaging improves visualization of architectural morphology. However, ongoing
investigations are required to determine whether OCT can identify optical markers which may
enable differentiation of dysplasia in vivo.
One obstacle in this challenge is ensuring correlation between in vivo OCT images and histologic
diagnosis from biopsy. Many histologic diagnoses of dysplasia are focal, implying that reliable
correlation of imaging with histology will be difficult to achieve in vivo. Groups have attempted
to overcome this by designing special OCT catheter probes which minimizing catheter motion
during imaging and enable immediate acquisition of biopsy samples from the imaging site after
imaging. Another strategy has been to use adenomatous colonic polyps as models for dysplasia,
since polyps are removed in entirety during polypectomy. 73
Registration can also be achieved by directly imaging biopsy specimens immediately after
excision. Figure 7.2 and Figure 7.3 shows preliminary ex vivo biopsy images of normal
squamous epithelium and a region at the junction between normal squamous and Barrett's
esophagus. The relatively homogeneous and uniformly scattering squamous epithelium can be
clearly distinguished from heterogeneous glandular epithelium.
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Figure 7.2: Left, Ex vivo OCT biopsy imaging of normal squamous epithelium. The squamous
epithelium is uniformly scattering. The highly scattering band corresponds to the bottom surface
of a glass coverslip used to minimize imaging aberrations. Right, Histology, Hematoxylin and
Eosin, 40x. (Wavelength 1.26 pm, Resolution 3.7 pm axial x 6 pm transverse)
m---250 um 250 um
Figure 7.3: Left, Ex vivo OCT biopsy imaging of junction between squamous epithelium and
Barrett's esophagus shows characteristic glandular structures (arrows). Right, Histology,
Hematoxylin and Eosin, 40x. (Wavelength 1.26 pm, Resolution 3.7 pm axial x 6 pm transverse)
Biopsy specimens are typically shallow, allowing imaging and correlation with specimens of
relatively superficial regions of the esophagus. However, precise registration possible by
imaging biopsies in entirety ex vivo may enable unambiguous identification of optical markers
associated with dysplasia. It is possible that the small size of specimens and therefore loss of
supporting tissue structure influences architectural integrity, which may alter the contrast of ex
vivo structures compared to in vivo imaging. Image analysis techniques will also likely be
required in order to identify optical markers which can be correlated to dysplasia both in ex vivo
and in vivo images. These questions are of significant interest and are being addressed in ongoing
studies.
CONCLUSION
Recent advances in OCT imaging technology have enabled improvements in axial resolution,
imaging speed, and imaging sensitivity, improved image quality and enabling studies to be
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performed in the clinical setting. Ex vivo investigations performed ex vivo in the pathology
laboratory examined the feasibility of using OCT for imaging normal and neoplastic pathologies
in the thyroid, intestinal tract, and breast. These studies elucidated the optimal imaging
parameters, potential and limitations of this technique, and established the microstructural
markers visible in OCT images that are characteristic of pathology in these organ systems. These
studies should serve as a useful baseline for development of new OCT technologies and aid in
interpretation of future in vivo investigations.
A major unresolved question is whether OCT is capable of detecting hallmarks of changes
associated with early dysplasia. This thesis has shown that larger-scale tissue architectural
features, such as glandular and ductal structure and epithelial thickening, can be visualized using
OCT in selected human tissue types. However, standard histologic features of dysplasia, such as
enlarged nuclei and increased nuclear-to-cytoplasmic ratio, are based on cellular characteristics
and may therefore require cellular-level imaging techniques to distinguish. The role of OCT in
early cancer detection may therefore depend on the ability to establish a definitive correlation
between tissue architectural organization and early stage disease. As with any diagnostic
technique, the relative effectiveness of OCT will need to be weighed against alternative methods.
Optical coherence tomography will ultimately require validation through extensive in vivo
patient studies to assess sensitivities and specificities for detecting early neoplastic pathologies.
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